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ABSTRACT
We have studied the multiplication of rhInovirus
type 2 in human embryo lung cells.
The work which will be described in this thesis
has been divided into three partso
I RNA replication
II Effect of the antiviral compound I.C.I. 65-709
on viral RNA synthesis.
III Rhinovirus induced polymerase activity. The effect
of I.CoI. 65-709 on polymerase activity.
GENERAL INTRODUCTION
1Historical aspects - Classification
Intensive study of the common cold led to the
finding that its main cause was a virus (Andrewes, 1965)0
In 1953, Andrewes et alo reported the in vitro culture of
a virus obtained from a human being suffering from a cold.
These experiments could not be repeated for about 8 years,
then in 1960, Tyrrell and Parsons reported that viruses
which could induce cytopathic effects in vitro could induce
cold~ when inoculated into volunteerso They found that a
temperature of 330C in a medium with a low pH of 6.8
optimized the growth of the virus.
Among the numerous names suggested for the
common cold viruses,rhinoviruses is the one generally
accepted today (Virus Subcomm. Int. Nomencl. Comm., 1963).
Rhinoviruses were defined as ether stable RNA-containing
viruses which were smaller than 30nm in diamete~ and
labile below pH 5 (Tyrrell & Chanock, 1963) and they were
placed as a separate subgroup inside the picorna-virus
group (International Study Group for Enteroviruses, 1963).
However this definition included some other viruses such
as foot and mouth disease virus (FMDV), vesicular
exanthema virus (Wawrzkiewicz et al., 1968) and feline
picornavirus (Burki, 1965). Studies on physicochemical
properties of many picornaviruses revealed many differences
among the members of the group and a reclassification
"has been suggested (Newman et al., 1973) in which physico-
chemical properties are taken into account together with
the biological properties.
Biological properties
The ratio of physical particles to p.f.u. has
been estimated as 2,210 for rhinovirus type 2 and 6,500
for rhinovirus type 14 (stott & Killington, 1972). These
values are well below the particle: p s f' .u. ratio of
poliovirus (Korant et al., 1972).
2Rhinoviruses can grow in the laboratory in
human cells (H-strains) or in both human and mOlLl{:eycells
(M-strains) (Tyrrell & Bynoe, 1966)0 However it has been
found that H and M strains may exist within the same
serotype (Phillips et al., 1965) and it has also been
reported that some H-strains can grow in monkey cells
(Douglas et al., 1966).
The first plaque assay of rhinoviruses was
described by Parsons and Tyrrell in 1961 who counted
microplaques under fluid overlay. A year later Porterfield
reported a plaque assay in human embryo lung cells under
agar (Porterfield, 1962). However in 1966, Fiala and
Kenny reported that increased Mg++ concentration enhanced
plaquing and demonstrated the appearance of plaques in
2-3 days using HeLa cells. This assay has proved to be
applicable to the 55 known serotypes tested (Connant
et aL, , 1968; Fiala, 1968).
Rhinovirus infectivity can be neutralized by
specific antisera and this reaction is the basi8 of
classification within the rhinovirus group. The rhinovirus
collaborative programme, which was initiated by the
World Health Organisation, to compare all the reported
rhinoviruses in cross neutralization tests has revealed
55 distinct serotypes during the first phase of its study
(Kapikian et al., 1967). The number has been increased to
89'after the second phase (Kapikian et al., 1971) and 17
other candidates are currently being investigated (stott
& Killington, 1972). The existence of serolvgical
variation within a serological type and of some low level
cross reactions between serotypes led to the further
classification into antigenic groups (Fenters et al., 1966).
Immunodiffusion reactions between rhinoviruses
and their antisera revealed one precipitin line (Acornley
et al., 1968). However heating rhinovirus type 2 at 56°c
for 30 min results in a failure of the virus to combine
with neutralizing antibodies or induce antibodies (Doggett
et al., 1963; Dimmock, 1967) suggesting a change or 1055
of antigenicity.
Rhinoviruses 1A and 2 have been used to
demonstrate complement fixation (Mogabgab, 1962; Chapple
et alo, 1967) however the distribution of complement
fixation"antibody did not correlate with that of the
neutralizing antibody and their specificity was uncertain.
Physicochemical properti~s
Rhinoviruses are similar to most picornaviruses
as far as morphology, size and symmetry are concernedo
They are of hexagonal shape wi~h"a diameter of 18 to 28 nm
(Hamparian et al., 1961; Fiala, 1968; Blough et al., 1969;
Kawana & Matsumoto, ~971). The hexagonal shape of the
particles suggests icos~hedral symmetry (Mayor, 1964;
McGregor et al., 1966; Gerin et al., 1968).
Dirnmock and Tyrrell (1964) first studied the
sedimentation properties of rhinoviruses. They found a
sedimentation coefficient in the range of 122S to 165S
which did not significantly differ from the value
obtained for poliovirus. Since then, velocity centri-
fugation has given conflicting results. Poliovirus was
reported to have the same sedimentation rate with rhino-
virus type 14 (McGregor & Mayor, 1971) and type 1A
(Medappa et al., 1971). However in these reports the
virions had first been purified by Csel-gradient
centrifugation and this may have increased the sediment-
ation rate of the rhinoviruses (Gerin et al., 1968)0 The
pest results were obtained by co-sedimentation studies.
Two reports on such studies have recently appeared:
KoSrant et al. (1972) estimated an S value of 150 for
type 2, type 14 and equine rhinovirus by co-sedimentation,
assuming the sedimentation coefficient of poliovirus to
be 156s (Schaffer & Schwerdt, 1959; Schwerdt & Schaffer,
1955). Newman et al. (1973) used FMDV (146s) as a marker
in sucrose gradients and found that rhinovirus type 2 and
bovine enterovirus sedimented with a rate of 156s while
rhinovirus type 4 and equine rhinovirus had a sedimentation
coefficient of 150S.
The buoyant density of rhinoviruses has been
I.
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investigated by a number of groups (Rowlands et al., 1971;
Newman et ale, 1973; Chapple & Harris, 1966; Dans et al.,
1966; McGregor et al., 1966; Gerin et al., 1968; Ko~ant
et alo, 1970; Thomas et al., 1970). Rowlands et al. (1971)
pointed out the errcrs which can arise when the viruses
with the higher density are centrifuged for prol~nged
periods; for example, the buoyant density of FMDV
increased from 1.43 glml to 1.46 glml when the sediment-
ation time was increased from 5 to 100 hours. The same
people reported that the density of acid stable picorna-
viruses was not increased by prolonged sedimentation in
CsCI. Nevertheless the buoyant density of rhinoviruses is
placed by these investigators in the range of 1038 -
1 .41 g/ml. The wide range of denSity values could be
explained by'differences in experimental conditions used
by the various groups as well as to the different strains
of the virus used. It seems by co-sedimentation with FMDV
that rhinoviruses have a buoyant density between that of
enteroviruses (1.33 - 1.34 g/ml) (Mattern, 1962; Schaffer
& Frommhagen, 1965; Mandel, 1962; Rowlands et al., 1971;
Martin et al., 1970) and FMDV (1042 - 1.51 g/ml) (Rowlands
et al., 1971; Newman et al., 1973; Trautman & Breese, 1962;
Brown & Wild, 1966; Liehermann & Gralheer, 1968). Equine
rhinovirus has a higher density (1.45 g/ml) (Rowlands et
al., 1971; Newman et al., 1973) and different base
composition (see below) from human rhinoviruses and should
therefore be classified in a separate sub-group (Newman
et al., 1973).
Only one report has appeared on the molecular
weight of the virus (McGregor & Mayor, 1971). Calculations
based on sedimentation rate, diffusion coefficient and
partial specific volume give a molecular weight of 7.1 x
106 dal tons.
Chemical analysis of purified rhinovirus 14
indicates 70.2% of the virion is protein and 29.8% RNA
(McGregor & Mayor, 1971).
5Nucleic acid and proteins of the virion
The genetic material of rhinoviruses is single
stranded RNA which has a molecular weight within the
range of 2.4 - 2.8 x 106 daltons (McGregor & Mayor, 1971;
Van Elsen et alo, 1968; Nair et al., 1971; Koliais &
Dimmock, 1973). Since the molecular weight of the virion
is about 7 - 8 x 106 daltons and the RNA content is only
30% it is apparent that only one strand of RNA is con~ained
per virion. Base ratio analysis of the RNA has shown
rhinoviruses to have a uniquely high adenine content
(Brown et alo, 1970; McGregor et alo, 1971; Newman et al.,
1973) which distinguishes them from the other picorna-
viruses including equine rhinovirus. Since this thesis is
directly concerned with'the various RNA species induced
by the virus, this topic will be discussed extensively in
the chapters to follow.
Like the other picornaviruses, rhinoviruses
possess four virion polypeptides (VP) (Korant et al.,
1972; Medappa et alo, 1971; stott & Killington, 1973)0
VP1, VP2 and VP3 are the major polypeptides with molecular
weights of 37,000, 26,000 and 24,000 daltons and vp4 a
minor polypeptide with a molecular weight below 10,000
daltons. Korant et alo (1970) reported that rhinoviruses
lacked the minor polypeptide but later agreed to its
presence. This earlier failure to detect it was caused
by a procedural artefact as they stated in a more recent
report (Korant et al., 1972). A fifth polypeptide VPO or
E has been reported by Medappa et al. (1971), but it has
not been detected by others, the significance of this
finding remains to be solved in the future.
The proteins of equine rhinovirus have been
studied by Korant et al. (1972) who found them all to be
of higher molecular weight than human rhinovirus proteins.
An equivalent molar ratio of the four polypep-
tides has been calculated by Medappa et al. (1971) although
stott and Killington (1973) reported a 1:1:1:0.5 molar
ratio which is similar to that found for mouse encephalo-
6myelitis (ME) virus (Rueckert et al., 1969), bovine
Cll"""enterovirus (Johnston & Martin, 1971)~ FivIDV (Talbot
et aL, , 1973).
Site of replication
All available evidence indicates that picorna-
viruses multiply in the cytoplasm. Cytoplasmic RNA
replication was shown first by autoradiography· (Franklin
& Rosner, 1962; Hausen, 1962) and the RNA synthesizing
enzymes are found together with viral RNA and viral
proteins as large membrane bound aggregates in the
cytoplasm of the cell (Holland & Bassett, 1964; Dalgarno
& Martin, 1965; Eason & Smellie, 1965; Penman et al.,
1964; Beker et al., 1963). Since the rhinovirus induced
polymerase is found in the cytoplasm (Yin & Knight, 1973),
it is likely that the cytoplasm is the site of replication
of the rhinoviruses.
Multiplication cycle
The time course of the multiplication cycle
of picornaviruses depends on a number of factors. Amongst
the most critical is the type of virus, the multiplicity
of infection (Baltimore et al., 1966), the type of cells
in which the virus is growing and the nutritional or
mitotic state of the cells. Studies on the early events
of the replication of some rhinoviruses grown in HeLa
cells have been done recently by Lonberg-Holm & Korant
·(197~). They find that although the rate of attachment
to cells of rhinovirus type 2 is greater than that of
type 14, the number of receptor sites is similar for
each type. Competition experiments on the saturation of
the receptor sites on the cell surface revealed that
the sites for type 2 are different from those for type
14. However excess rhinovirus type 2 blocks attachment
of type 1A and excess of type 14 blocks type 51,
indicating that the different serotypes might fall within
certain receptor families. Another interesting aspect
revealed by Lonberg-Holm & Korant (1972) is the fact
that attachment of some rhinoviruses to the cell, in
7p~ase
addition to the eclipse is temperature dependent.
Some efforts have been made to analyse the product of
eclipse. It is believed to be a slower sedimentating part-
icle (135S) which is not infectious. It lacks vp4 but
still contains RNA. Upon CsCI centrifugation these particles
lose polypeptide VP2. It is possible that the particles
which lack polypeptide vp4 represent the first step of tIle
virus uncoating procedureo However since the majority of
picornavirus particles are non-infectious there is no way
of determining if the 135S particles are degraded non-
infectious particles or repres~nt the early stages of
productive infectiono
The majority of the progeny virus remains cell
associated when the plateau of virus production is reachedo
Over 90% of the virus is cell associated when the virus
grows in KB or HEL cells and over 99% when it grows in
HeLa cells (Thomas et alo, 1970; Koliais & Dimmock, 1973;
Fiala & Kenny, 1967; stott & Heath, 1970)0 The amount of
released virus is increased, without affecting the total
virus yield, by a high concentration of magnesium ions
(stott & Heath, 1970)0
8MATERIALS AND METHODS
9MATERIALS
1. Viruses
Rhinovirus type 2 was obtained from Dr. E. J. stott,
poliovirus type 1 (L Sc 2 and b) from Dr. M. S. Pereira
and bovine enterovirus (VG-5-27) from Dr. S. J. Martin.
Guanidine resistant rhinovirus mutants were prepared in
this laboratory by Dr. N. J. Dimmock.
2. Cells
Human embryo IWlg (HEL) cells of the MRCS line were
obtained from Mr. J. Po Jacobs (National Institute for
Medical Research, Hampstead Laboratories). Both L132
and HeLa cells were obtained from Dr. E. J. stott. Baby
hamGter kidney cells (BHK 21, clone 13) were obtained
from Dr. D. H. Watson. Chick embryo fibroblast (CEF)
cells were routinely prepared in this laboratory from
11 days old fertilized eggs (Walters et al., 1967).
3. Biological materials
Bovine albumin (fraction V) was purchased from Sigma
Chemical Co. st. Louis, Missouri, UoSoA.
Deoxyribonuclease (ribonuclease-free, electrophoretic-
ally purified) was obtained from Worthington Biochemical
Corp., Freehold, N. J., U.S.A; pancreatic ribonuclease
and pyruvate kinase from the Boehringer Corporation,
London. Trypsin was obtained from Difco Laboratories,
Detroit, U.S.A.
Eagle's minimal e~sential medium and 199 medium were
purchased as ten-fold concentrates from Wellcome Reagents
Ltd., Beckenham, England.
ATP, UTP, GTP and CTP (synthetic or from equine muscle)
were purchased from Sigma Chemical Company Ltd., London.
Actinomycin D (AMD) was donated by Merck, Sharp and
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Dohme Ltd., Rahway, New Jersey, U.SoA.
Penicillin and streptomycin were obtained in the form
of crystomycin which contained 600 mg (106 units) of
penicillin to 1 g streptomycin. Crystomycin was purchased
from Glaxo Laboratories Ltd., Greenford, England. Kana-
mycin was obtained from Winthrop laboratories.
(3H]-uridine labelled HeLa nucleolar RNA was a
generous gift from Dr. A. Meager.
4. Chemical materials.
65-709 gluconate was kindly provided by I.C.Io Ltd.,
through Dr. R. A. Bucknall.
Sodium lauryl (or dodecyl) sulphate (SDS), ammonium
persulphate, gentian violet, diethylpyrocarbonate and
uridine were all purchased from BoD.H. Chemicals Ltd.,
Poole, Dorset.
Dimethylsulphoxide and phenol were obtained from
Hopkin and Williams Ltd., Chadwell Heath, Essex, England.
Phenol, ether and ethanol were redistilled before use.
Phospho(enol)pyruvic acid, guanidine hydrochloride
and cycloheximide were obtained from Sigma Chemical
Company Ltd., London.
NNN'N' -Tetramethylenediamine (TEMED) and NN'-
- methylenebisacrylamide were both purchased from Eastman
Kodak Company, Rochester, New York, U.S.A. Bisacrylamide
was recrystalized before use from acetone as described
by Loening (1967).
Acrylamide was a gift from Fluka, Switzerland.
Clela~d's reagent (dithiothreitol) was obtained from
Calbiochem., London.
Agarose was obtained from L'Industrie Biologique
Francaise S.A., Gennevilliers (Seine), France.
2,5 -Diphenyloxazole (PPO), 1,4 -di(2 - (5 -phenyl-
oxazolyl» -benzene (POPOP) and naphthalene, all
scintillation grade, were obtained from Nuclear
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Enterprises (GoBo) Ltd., Edinburgh, Scotland. Aerosil
standard silica was obtained from Bush, Beach, Segner
and Bayley Ltd., London.
5. Radioactive materials
All radioactively labelled compounds were obtained
from the Radiochemical Centre, Amersham.
6. Media
10% growth medium. Minimal etisential medium was supple-
mented with 10% (v/v) calf serum and adjusted to pH 7.4
with 5% (w/v) sodium btcarbonate solution. Peni~illin and
streptomycin were added to final concentrations of 60 ~g
(100 units) and 100 ~g per ml respectively.
Maintenance medium was identical to growth medium except
that the concentration of calf serum was 2% (v/v).
Overlay medium was identical to maintenance medium except
that 0.5% (w/v) of agar was included.
storage medium. Minimal essential medium was supplemented
with calf serum and dimethylsulphoxide to a final
concentration of 10% (v/v).
7. Buffers and solutions
RNA extraction buffer was 0.05 M tris, 0.1 M sodium
chloride, 0.0025 M ethylenediamine tetra acetate (disodium
salt)(EDTA), adjusted to pH 7.5 at 200 with hydrochloric
acid.
Electrophoresis buffer. This was prepared as d~scribed
by Loening (1967).
A concentrated stock solution was prepared as follows:
tris 43.5 g
NaH2P04.2H20 46.8 g
EDTA Na2.2H20 3.7 e
made up to 1000 ml with glass distilled water. For use as
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electrophoresis buffer, the stock solution was diluted
10 x and SDS added to a final concentration Of 0.2% (w/v)
Acrylamide stock solution. This contained 15 g acrylamide
and 0.75 g bisacrylamide in 100 ml of glass distilled
owater. It was stored in the dark at 5 C.
Standard saline citrate (SSC) was a solution of 0.15 M
sodium chloride, 0.015 M trisodium citrate, adjusted to
pH 8.4S'with HCI.
Gentian violet stain was a solution of 1% (w/v) gentian
violet and 20% (v/v) ethanolo
Phosphate buffered ealine (PBS) was a solution of 0.15 M -
NaCl, 3.4 mM - KCl, 10 IT'f.! - Na2HP04 and 2 mM KH2P04, pH 7.4
(Dulbecco and Vogt, 1954)0
Formol saline consisted of 4% (v/v) formaldehyde in
85 mM NaCl, 0.1 M-Na2S04'
8. Scintillation mixtures
Toluene scintillation mixture consisted of 6 g PPO and
0.73 g POPOP dissolved in 1 litre of toluene.
Triton-toluene scintillation mixture consisted of toluene
scintillation mixture and triton X-100, emulsified in
the proportions 2:1.
Gel scintillation mixture consisted of a mixture of 50 g
naphthalene, 7 g PPO, 150 mg POPOP, 30 ml absolute alcohol
and 200 ml toluene, made up to 1 litre with dioxane 35 g
silica gel was added and the mixture blended for 2 min.
METHODS
1. Subcu'lturing of cell lines.
HEL, HeLa, L132 and BHK 21 (clone 13) cells were all
maintained in a similar way except that HeLa cells were
treated with kanamycin to combat mycoplasma at 2 - 3 month
intervals. Apart from the HEL cells, which were grown in
flat bottles, all others were grown in both flat and roller
bottles. The following method was used:
a. Trypsinisation. The medium from the confluent bottles
was removed and the mon~layer washed with approximately
10 ml trypsin solution (0.2% trypsin' in PBS). 1 ml of the
same trypsin solution was added and the bottles were
incubated at 37°e until the cells came off the glass
(usually 2-4 min). When all or nearly all the cells were
detached, 10 ml oL growth medium was added and the cells
were suspended in this medium by pipetting, and the
growth medium was then added. HEL cells were diluted
1 : 3 and the other cell lines 1 : 6. The freshly seeded
bottles were either gassed with 5% e02 in air for 20
seconds or incubated with loose caps inside a gassed
incubator.
ob. Growth. The cells grow at 37 e. HEL were confluent
after 3 - 4 days and the other cell lines after 7 days •
.HEL cells lasted up to 35 - 40 passages before cell
division slowed down and the cells degenerated. The cells
were maintained happily at 330e with maintenance medium.
c. Preservation in liquid nitrogen. The cells were
trypsinized as usual and suspended in 10 ml growth medium
as described under (a). They were pelleted in the bench
centrifuge for 2 min and the cells obtained from one
confluent bottle were suspended in 1 ml of storage medium.
They were then transfered to an ampoule which was sealed
in a flame. The ampoule and contents were then gradually
cooled at the rate of 1-20e per min by placing in a
polysterene container at _20oe for 1 h and at -Iooe for
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2 h. The ampoules were then placed in liquid nitrogen.
To recover the cells the ampoules were thawed rapidly in
oa water bath at 37 C, and the cells transfered into a
150 ml bottle containing about 30 ml of growth medium.
Cells were incubated at 37°C. The medium was replaced with
fresh growth medium immediately after the cells stuck on
the glass (usually between 6 - 11 h after they were thawed)
since dimethylsulphoxide is toxic.
Since the HEL cells were being used continuously care
was taken in order to have the required stocks. Many
ampoules containing cells of early passage were therefore
stored in the liquid nitrogen. An ampoule was recovered
from the liquid nitrogen when the current cell line
reached pass 30.
2. Preparation of virus stocks
a. Rhinovirus stocks were prepared using either L132 or
HeLa cells in the following manner: 30 million cells were
suspended in a roller bottle containing about 250 ml of
growth medium with 001% bicarbonate. The bottles were
orolled at 37 C and growth medium containing 002%
bicarbonate was replaced after 2 days. When cells reached
confluency (usually 3 days later) the growth medium was
replaced with 50 ml of MEM and 0.2% bicarbonate containing
no calf serum and the bottles were allowed to roll for
30 mins. The medium was then replaced with 10 ml of the
virus suspension (107 pfu/ ml) wh t ch was adsorbed at 330C
for 1 hour. 50 ml of 2% MEM were added and the bottles
were rolled at 33°C for 24 hours. The bottles were then
shaken vigorously and if all the cells were not detached
from the glass 50 ml more of fresh medium was added and
incubation continued for a further 24 hours at 330C. The
cells were broken by freezing and thawing and the cell
debris was removed by low speed centrifugation. Stocks
were kept frozen at -70°C without any significant loss
of infectivity over a period of several months. The titre
8of the virus prepared by this method was around 10 pfu
per ml as titrated with HeLa cells. The yield of virus
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Fig. 1. Kinetics of virus adsorption by HeLa cells.
Confluent monolayers were infected at the same mult-
iplici ty of infect ion and wer-e overlayed at the
indicated times after infection. The number of plaque~
counted 3 days later is plotted against the time the
virus was allowed to adsorb.
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from HEL cells was approximately 10 times less than L132
or HeLa cells.
b. Po Ld.ov Lr-u s , The best titres (up to 2 x 109 pfu/ml)
were obtained when the virus was grown in HeLa cells
using the method used for rhinovirus. The only difference
was that the cells infpcted with poliovirus were rolled
at 37°C.
c. Bovine enterovirus was grown in BHK 21 cells as
described by Martin, Johnston and Clements (1970).
Monolayers of BHK cells infected with virus were rollpd
at 37°C overnight with MEM without serum. The cell sheets
were completely disrupted and the virus harvested and
stored at -70oCo
d. Guanidine-resistant·rhinovirus mutants. Rhinovirus
was adapted to grow in the presence of guanidine hydro-
chloride by titrating the vi~us in HEL mono layers in
rolled tubes containing 20,60 or 100 I-Lg/ml of inhibitor
(Acornley et al., 1968). Virus growth was detected by
cytopathic effects and the highest dilution of virus
which grew at the highest concentration of guanidine was
passaged again. Complete resistance was achieved by the
fifth passage and stocks were prepared from virus of the
seventh passage. Plaque titration in HeLa cells showed
that the resistant mutant was not significantly inhibited
by either 100 or 200 I-Lg/ ml guanidine.
3. Adsorption of virus by HeLa cells
In this experiment the kinetics of virus adsorption
in HeLa cells were studied. The stock virus was diluted
to 4 x 102 pfu / m.l., 15 small plastic plates confluent
with HeLa cells were infected with 0.2 ml of the diluted
virus and incubated at 33°C for 15, 30, 60, 90 and 120
mins. After each of these periods the plates were washed
and overlayed and incubated at 33°C. Plaques were counted
as described in the next experiment.
The results obtained are shown in Fig. 1 which shows
Virus dilutions
Plate 1 • Rhinovirus plaque
assay in HeLa cells
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that maximum virus adsorption occurred only after 90 mins
adsorption at 33°C.
4. Assay of infectious virus
The infectivity of all virus samples was titrated
by plaque assay:
a. Rhinovirus was titrated in monolayers of HeLa cells
by a modification of the method described by stott and
Heath (1970). The cells obtained from one 1-litre flat
bottle were seeded into 8 - 10 petri dishes (5 cm diameter)
oin 5 ml of growth medium and were incubated at 37 C for one
day. The medium was removed and the plates were inoculated
with 002 ml of virus diluted in maintenance medium.
Virus was allowed to adsorb for 90 min at 3JoC. The
inoculum was then removed and the plates were incubated
with 5 ml of overlay medium at 330C for 3 days~ The cells
were then fixed with buffered formol saline, the agar
removed and the cells stained with 1% gentian violet in
20% alcohol (Plate 1).
b. Poliovirus was titrated using the same plaque assay.
c. Bovine enterovirus was titrated in BHK cells as
described by Martin et al., 19700 The cell sheets of the
confluent mono layers were washed 3 times with calf serum-
free medium and were inoculated with 0.2 ml of the virus
dilutions. After 30 min incubation at room temperature
the sheets were overlaid with 0.9% agar in Eagle's
medium without calf serum. Plaques developed within 48 h
at 37°C and were visualised by fixing with formol saline
and staining with methylene blue.
d. Rhinovirus guanidine resistant mutants were titrated
in the same way as the wild type rhinovirus. When 1 or 2 mM
guanidine was included in the overlay no difference was
obtained in the infectivity titres, although the same
concentration of guanidine prevented the formation of
plaques when wild type rhinovirus was assayed.
t
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Fig. 2. Sedimentation of concentrated [3H] -uridinc
labelled virus on a 15 to 45% sucrose gradient at
·65,000 g for 3 to 5 h. Fractions of 1 ml were
collected and the radioactivity of 100 ~l ~amples
was determined (0 • ). Only the infecti vi ty (0--0)
of the peak fractions is shm"n.· Inset: RNA wa s
extracted from gradient fractions 6, 7 and 8 alld
electrophoresed on polyacrylamide gel. Ribosomal
RNA markers from HeLa cells were co-electrophoresed
and detected by optical density measurements.
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5. Labelling and purification of rhinovirus
Confluent mono layers of L132 were infected as described
above. 250 ~C of [3H]-uridine was added at the onset of
the cytopathic effect. Virus was harvested after a
labelling period of about 5 h. Purification of the labelled
virus was carried out as described by Brown and Cartwright
(1963) for FMDV. After the cell debris was removed by low
speed centrifugation an equaJ volume of cold PBS saturated
with ammonium sulphate was added, and the solution
allowed to stand at 4°c for 1 h.The resulting precipitate
was collected by centrifugation at 3,000 rpm for 30 mins
and was resuspended in 50 ml of cold PBS. The suspension
was then centrifuged fo~ 10 min at 10,000 rpm using the
8 x 25 MSE angle rotor to remove insoluble debris and the
viru~ was pelleted at 30,000 rpm for 1 h using the same
rotor. The pellet was resuspended in 1 ml PBS containing
1% (w/v) sodium dodecyl sulphate (SDS) and it was layered
on the top of a sucrose gradient (15-45% sucrose in PBS)D
The gradients were cent~ifuged for 3~ h at 25,000 rpm
using the 3 x 23 ml MSE rotoro 1 ml fractions were
collected by puncturing the bottom of the tubes containing
the gradients. Radioactivity was determined by counting
0.1 ml of each sample in a liquid scintillation counter.
The peak fractions were titrated for infectivity and the
results shown in Fig. 2. A coincidence of infectivity
and radioactivity is observed.
The peak fractions were pooled together, dialyzed
overnight against PBS to remove sucrose and the volume was
reduced by vacuum dialysis. Virion RNA was then extracted
as described below and was analysed by polyacrylamide gel
electrophoresis. A single peak of radioactivity was found
(Fig. 2, inset) of MW around 2.8 x 106 daltons as estimated
from the ribosomal RNA markers.
6. Effect of actinomycin D on cellular RNA synthesis
These experiments were carried out in order to
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establish the conditions necessary for total inhibition
of cellular RNA synthesis.
a. Time course of i.nhibition
Of six 50 mm Petri dishes confluent with HEL cells, four
were treated w i.t.h 2 [.Lg/ml of AMD, and two served as
untreated controls. Two of the AMD-treated cultures were
labelled with 0.5 [.LC/ dish of PH J-uridine between 1 and
2 h after the AMD was added and the other two between
3 and 4 h. The two control plates were similarly labelled
for one hour. The same expor-Lmerrt was done in parallel
using L132 cells. TCA-precipitable radioactive material
was assayed using the method already described.
The results (Table 1) indicate that the cellular RNA
synthesis is inhibited by 98% when the cells are treated
for 3 h 'vith 2 [.Lg/ ml of AMD before labelling.
b. AMD concentration required for inhibition
Duplicate plates of HEL or L132 cells were treated for 3 h
with increasing amounts of AMD. Two plates in each case
did not receive any AND and were used as controlso At the
end of the three hours the cells were pulsed for 1 h with
[JH] -uridine (0.5 [.Lc/ pLate), and the TCA-precipi table
radioactive material was assayed.
The results (Fig. 3) show that total inhibition of
cellular RNA synthesis occurs when they are treated with
1 I-Lg/ ml of AMD for 3 hours.
7. Infection and labelling of HEL cell monolayer cultures
Most of the experiments were carried out in HEL cell
mono layers which were grown in 1 litre flat bottles on a
surface area of 115 cm2• This is occupied by between
40 and 50 million cells when the monolayer is confluent.
A multiplicity of 5 ··10 p.f.u. / cell was used for most
experiments; each bottle was infected with 5 ml of stock
virus containing 108 p s f' .u. / m.l, and allowed to adsorb
at 33°C for 1 hour. The inoculum was then removed, 30 ml
of maintenance medium was added and incubation continued
at the same temperature. AMD (1 [.Lg/ml) was added 4 hours
A B
o
Plate 2. Human cells in tissue cultures. A. Non infected HEL
cells. B. HEL cells infected with rhinovirus type 2 as seen
in the microscope at 12 h p.i. C. Non infected L132. D. L132
cells infected with rhinovirus type 2 at 15 h p.i.
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Fig. II·.Comparison of the acid-soluble
uridine pools in cells infected with
rhinovirus and non-infected cells. The
vertical axes indicate the percentage
of the a~id soluble counts of the
infecte d cells compared to that of the
non-infected controls.
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before the addition of the radioactive label. In experiments
where it was necessary to add the label early in the
replication cycle, the cells either were treated with
AMD prior to infection or were given a higher dose of AMD.
[JH]-uridine or [14e]-uridine was used to label the
viral RNA. At the required time the AMD-containing
maintenance medium was replaced with 5 ml of the same
medium containing either 20 lLc/ ml of PH ]-uridine or
5 lLc/ ml of e "c ]-uridine. The usual duration. of the
isotope pulse was of 2 hours, and when shorter pulses
were required more radioactive label was added.
When the infected cells were observed under the light
microscope a cytopathic effect was visible after 8 - 9 h
post infection. Plate 2 shows infected and uninfected
cells as they usually appear under the microscope at
12 h after infection.
8. Uridine uptake by inf'ected cells
The incorporation of'uridine into virus RNA depends
upon the ef'f'iciencywith which the cells are able to
take up [JH]-uridine into intracellular pools.
Consequently to determine the variation in pool size, the
acid-soluble [JH]-uridine present in non-infected cells
and in infected cells throughout the growth cycle was
measured.
50 mm plastic Petri dishes confluent with HEL cells
were in:fected and labelled wi th 0.2 !-Lc/ di.eh [JH J-uridine
at the times indicated in Fig. 4. Non-inf'ected dishes
were treated in parallel in exactly the same way. AMD
(1 !-Lg/ml) was present in all plates. At the end of'each
pulse infected and non-inf'ected cells were assayed f'o~
TCA-soluble material as f'ollows. Af'ter the mono layers
were washed three times with cold PBS, 4 ml of' cold 5% TCA
were added to each dish f'or 30 min at 4°C. 0.5 ml of' the
TCA was assayed for radioactivity using triton-toluene
scintillation mixture. The percentage of'radioactivity
of' inf'ected to non-infected samples was plotted in Fig. 4~
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At the end of'the incubation of each sample, the cells
were observed under the light microscope and the c.p.e.
was noted (upper part of Fig. 4).
It is evident that while the cells remained free of
cytopathic ef'f'ects,the pool of' [JH]-uridine varied by
only 20%. At the onset of'the cytopathic effect, the
size of the radioactive uridine pool :fell gradually to
50% of the control value. This probably reflected the
numbers of cells which were detached from the mono Layer ,
since only cells remaining attached were assayedo
The same experiment was repeated with HeLa cells.
Similar results were obtained (Fig. 4 ).
9. Extraction of RNA
a. From infected cells
The infected mono layers were washed twice with cold
extraction buffer solution containing 100 mM NaCI, 50 mM
tris and 2.5 mM EDTA (pH 7.5) and the cells were lysed
into 2 ml of'the same buffer solution containin6' 1% (w/v)
SDS. RNA was extracted by shaking at room temperature
with two volumes of phenol saturated with extraction
buffer solution. The aqueous phase was separated by
centrifuging at 800 g for 7 mins. The phenol extraction
was repeated one or two times until the resulting aqueous
1ayer was c1ear. Residua1 phenol was removed from the
fina1 aqueous phase by three extractions with ether
saturated with extraction buffer. A stream of nitrogen
was passed over the sample to remove any remaining ether.
The RNA was then precipitated with J volumes of redistilled
ethanol at -20oC for over 10 hours.
b. From purified virions
The sarne extraction method was used. About 50 ~g cold
ribosomal RNA was added as carrier before th~ first phenol
extraction.
10. Extraction of nucleolar RNA
Weinberg and Pennman (1970) showed that HeLa cell
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ribosomal RNA, the 28S and 18S RNA's, were processed
from a larger RNA molecule of 4ss found in the nucleolus.
The 45S molecule was cleaved specifically by nucleolytic
enzymes in the nucleolus to give a series of RNA molecules
which were precursors of ribosomal RNA. The RNA molecules
found in nucleolar RNA had sedimentation coefficient
values 4ss, 41S, 36s, 32S, 28S, 24s, 20S and 18S. Usually
only the 45S, 32S, 28S and 18S are found in nucleolar RNA,
the other intermediate species being too short-lived to
be detected. However under certain conditions (infection
by poliovirus; Weinberg and Pennman, 1970, or in
confluent monolaYGrs of non-dividing HeLa cells) process-
ing of the intermediates is inhibited so that detection
of some short-lived intermediates is possible. using this
principle, nucleolar RNA labelled with 13HI-uridine was
prepared by Dr. A. Meager and was extracted according to
the method described by pe~an (1966) and Wagner et al.,
1967.
11. RNA polyacrylamide gel electrophoresis
The system described by Loening (1967) was used.
Polyacrylamide gels of 1.7 or 2.0% were supported by 0.5%
agarose and polymerized in 10 cm tubes of 0.7 cm internal
diameter.
a. Preparation of gels
2% polyacrylamide gels were prepared as follows: the
following solutions were mixed in a 250 ml spherical
'flask:
6.1 ml of H20
7.5 ml of 5 x electrophoresis buffer
5.0 ml of acrylamide stock solutian
The flask was placed into a 50°C bath and 18.6 ml of 1%
hot (50°C) agarose were added before the whole mixture
was degassed for 30 seconds. 0.025 ml of NNN'N' tetra-
methylethylenedia~ine and 0.25 ml of 10% ammonium per-
sulphate were added before the mixture was transfered into
the perspex electrophoresis tubes. Before the gels
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polymerised 50 ~l of H20 were layered onto the top of
each gel. After 30 mins the gels were extruded from the
tubes and the slightly diluted end of the gel removed
with a razor blade, leaving a clean flat sur~ace of
polyacrylamide/agarose mixture. The gels were drawn back
into the tubes before,use.
1.7% gels were prepared similarly, the proportion
of each solution was di£ferent:
8.25 ml H2O
8.80 ml 5 x buffer
5.00 ml acrylamide stock solution
22.05 ml 1% agarose
Details of the above solutions are given in the
'Materials' section above •
.£..:....!>reparationof the RNA sample for electrophoresis
RNA precipitated with ethanol was collected by centrifuging
for 20 mins at 1 ,000 g. The ethanol was poured off and
the RNA was dried with nitrogen. 0.1 to 0.2 ml of extraction
buffer solution was added and 0.01 ml of the RNA solution
was used for quantitative estimation of the RNA using
absorbance at 260 nm. Up to 60 ~g of RNA was electrophoresed
on.each gel. This RNA was made up to 5% sucrose before
loading to prevent mixing with electrophoresis buffer.
c. Conditions of electrophoresis
Electrophoresis was carried out using a Shandon disc
electrophoresis kit with the gels fitted vertically to
connect the upper and lower buffer reservoirs which
contained electrophoresis buffer plus 1% SDS. Extra care
was taken to remove any air bubbles trapped at the
bottom of the gels. The gels were electrophoresed for 1 h
at 50 volts before the samples were loaded. The samples
were electrophoresed at the eame voltage for between 3
and 5 hours.
d. Detection of cellular RNA after electrophoresis
After electrophoresis the gels were extracted from the
tubes directly into the cuvette of a Joyce-Loebl
"Chrom"oscan" densitometer and were analysed for material
absorbing at 260 run.Usually the DNA and the t.wo riLosomal
RNA species werc detected.
e. Detection of viral RNA bands
Gels containing radioactive material were first scanned
to detect the O.Do markers and were then frozen onto
....metal plates. Slices 1 mm thick wer'e cut, placed in
scintillation vials and dissolved in 0.2 ml of 100 volume
hydrogen peroxide by incubating at BOoC for 1 to 3 h
until the gels were completely dissolved. 10 ml of toluene/
triton scintillation mixture we.re added to each sample
which were then cooled at 4°c and counted in«'Packard
Tricarb series 3,001) liquid scintillation counter fitted
with a teletype digital line printer. Simultaneous
counting of [3Hl and [14e]radioactivity was carried out
using the channel-ratio method of Handler {1964} encoding
the information in ASC-2 code onto punched tape. The
results were calculated using an IoC.L. 1900 series
computer.
12. Ribonuclease treatr.lentof RNA
Salt concentration is the major factor which permits
the selective degradation of single or double stranded RNA
by ribonuclease (Baltimore, 1966). The following conditions
were used for the experiment which involved ribonuclease
treatment:
a. Degradation of both single and double stranded RNA
The RNA was disscIved in extraction buffer and it was
incubated for 30 min at 37°C with 10 ~g / ml of ribonuclease.
b. Selective degradation of single stranded RNA
The RNA was dissolved in double strength standard saline
solution (sse) pH B.45 and was then incubated for 10 min
at 37°C with 0.1 ~g / ml of ribonuclease. Ribonuclease
treatment was terminated by loading the RNA-RNAse mixture
onto the top of the polyacrylamide gels and electro-
phoresing the samples immediately.
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Fig. 5. Chase of [3H]-uridine by cold uridine. The total
acid-insoluble counts are plotted against the time after
the cold ur-Ldi.ne was added (0-----0 non-chased controls, 0--0
after the addition of 106 excess of cold uridine).
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130 Ribonuclease treatment of infected broken cells
After the cell sheets were washed twice with extraction
buffer, the cells were scraped from the glass into 2 ml
of 2 x SSC solution. The cells were broken by freezing and
thawing and were incubated at 37°C for 10 min in the
presence of 0.1 or 10 ILg/ml of RN:::tseoThe RNase treatment
was terminated by addition of 1% SDS (w/v) and 2 volumes
of phenol and the immediate extraction of RNA.
14. Deoxyribonuclease treatment. of RNA extracted from
infected cells.
Treatment of RNA with deoxyribonuclease (DNase)
necessitated further purification by ethanol precipitation
to remove traces of SDS which inhibit the enzyme. The
reaction mixture contained 10 ILg/ ml DNase and 10 mM
MgCl2 in extraction buffer solution, and was incubated
for 30 to 60 min at 37°C.
This procedure when applied to the RNA extracted from
infected cells resulted in the complete degradation of the
cellular DNA leaving the cellular or viral RNA intact.
15. Chas~~ of radioactive uridine
The possibility of chas~lradioactive uridine with
cold uridine was studied with HEL, HeLa, BHK and chick
embryo fibroblast (CEF) cells.
50 mm plastic Petri dishes confluent with cells of
each of the above cell types were incubated for 10 min
with 1 ml of maintenance medium per dish containing
4 ~,/ ml of [3H]-uridine. At the end of this period 2
dishes of each cell type were assayed for radioactivity
incorporated into acid-insoluble material as described
elsewhere. Into half of the remaining plates 0.1 ml of
10-3 M cold uridine was added and incubated at 37°C. At
the time intervals indicated in Fig. 5 two chased and two
control non-chased dishes were assayed for acid-insoluble
material.
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Fig. 60 Multiplication of bovine enterovirus
.,in BHK cells. Infectivi ty represents the total
yield of cell-associated and released virus.
Fig, 5 shows that the radioactive uridine label could
be chased and that the efficiency with which the chase
takes place depends on the cell type. The label was
chased most efficiently in CEF and HEL cells.
When viral RNA was to be chased the infected cells
were exposed to 10 l-Lc/ ml of PH] -uridine for 5 min at
9 h post in£ection otherwise the experimental conditions
described above were used.
16. Multiplication of bovine ~nterovirus in BHK cells
The bovine enterovirus - BHK cells system has been used
in one experiment in this thesis. The growth curve of the
virus in these cells is described here.
Confluent BHK cells in 50 mm plastic Petri dishes were
washed with buffered Earle's solution and were infected
with 0.1 ml of virus at a multiplicity of 5 -10 p.f.u. /
cell. After 30 min incubation at room temperature the
unadsorbed virus was removed and the cells were incubated
at 37°C with Eagle's medium without calf-serum. At the
intervals indicated in Fig. 6, dishes were removed from
the incubator and were titrated for total virus infectivity
as described above. Fig. 6 shows that virus infectivity
was first detected at 3 h and then increased exponentially
until 5 h when it reached a plateau.
A growth curve of bovine enterovirus in BEL cells is
shown in "Results Part II".
17. Extraction of rhinovirus RNA-dependent RNA polymerase
activity from infected cells
The cellular fraction used for the polymerase assays
was extracted following the method described by Yin and
Knight (1972): Monolayers of either HeLa or HEL cells were
infected in the presence of AMD (1 l-Lg/ ml). At the end of
9 h the cell sheets of 5 bottles (about 225 x 106 cells)
were washed twice with cold PBS and the cells of each
bottle were scraped Lntto 2 ml of PBS. The suspensions
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were pooled together and collected by lbw speed centri-
fugation. The cell pellet was frozen at -70oC and cells
were suspended in 10 ml of cold buffcr contLininb" 0.5 M
tris (pH 7.2), 0.002 M MgCl2 and 0.1 M NaCI at 4°c for
10 min. Disruption was completed with 14 strokes in a
stainless-steel Dounce homogenizer with a clearance of
0.002 ins; the nuclei were removed by centrifugation at
800 g for 5 min. The supernatant fraction was.spun at
30,000 g for 20 min and the pellet was suspended in 0.5 ml
of buffer containing 0.05 M tris buffer pH 8.0 and 0.01 M
NaCI. This fraction contained cytoplasmic membranes and
it has been reported to ccntain the majority of the
polymerase activity (Yin & Knight, 1972).
18. Assay of rhinovirus RNA-dependent RNA polymerase
activity
The in vitro RNA polymerase assay described by Yin
and Knight (1972) was used with few minor modifications.
0.1 ml of the enzyme sample was incubated at 330C for
30 min with 0.1 ml of a mixture containing the i'ollowing
constituents: 0.25 ~moles of the 5' -triphosphates of
adenine, cytidine and uridine; 0.002 ~moles of guanosine
triphosphate; 10 ~moles of tris buffer pH 8.0; 1 ~mole of
MgCI2; 0.25 ~moles of phosphoenolpyruvate; 5 ~g of phospho-
enolpyruvate kinase; 1 ~g of AMD; 1.3 ~moles of dithio-
threitol and 2.5 ~c of [JH]-guanosine-triPhosPhate. The
reaction was terminated by adding 1 ml of ice cold solution
containing 0.1 M sodium pyrophosphate and 6~ TCA. The
precipitate was washed and collected after 1 h by either
of the two following methods:
Method 1 The precipitates were collected on Whatman GF/C
glass fibre discs using a millipore 302S sampling manifold
(Millipore (UK) Limited, Wembley, Middlesex). The discs
were washed 3 times with 5 ml of 5~ (w/v) TCA containing
0.1 M sodium pyrophosphate, 3 times with 5 ml of an
ethanol-ether (3:1 volumes respectively) mixture and twice
with 5 ml of ether. After drying in air for 15 min the
discs wer-.eplaced in scintillation vials and were counted
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using triton-toluene scintillation mixture.
Method 2 The samples were spun in the 4L MSE centrifuge
for 15 min at 2,000 rpm. The precipitates were washed 3
times with 5% TeA, 0.1 M pyrophosphate solution and
collected each time by centrifugation. The final
precipitate was dissolved in 0.5 ml 0.2 N NaOH and it was
counted using 20 ml of the gel scintillation mixture.
Duplicate samples washed according to method 2 were
more consistent than the duplicates obtained when method 1
was used.
19. Extraction and analysis of the RNA polym~rase product
When the product in an RNA polymerase assay was to
be analysed by polyacrylamide electrophoresis the reaction
volume and the amount of reactants were doubled, the
amount of j3H]-GTP was increased 20-fold and cold GTP was
omitted. A ter 30 min of incubation at 3JoC, the reaction
was terminated by addition of 2 ml of cold extraction
buffer and 5 ml of phenol. The RNA was extracte~ as
described above except that SDS was not used in the
extraction buffer. RNA was then analysed by polyacrylamide
gel eectrophoresis as described in M 11.
20. Determination of protein concentrations
Protein concentrations were determined by a modification
of the method of Lowry et al. (1951) described by Oyama and
Eagle (1956) with bovine serum albumin (BSA) as standard.
21. RNA determination
RNA was determined by absorbance at 260 nm assuming
that the relationship established for yeast RNA, where
20 OD260 was equivalent to 1 mg/ml RNA, was generally
applicable.
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22. Measurement of cellular macromolecular synthesis
After the 50 mm plastic Petri dishes with confluent
cell sh~ets were treated as demanded by each particular
experiment they received a pulse of 0.5 ml 01 either
[3H]-uridine or [3H1-valine and [14c]-thymidine
respectively. At the end of the pulse the cell sheets
were washed 3 times with 5 ml of ice cold PBS, 3 times
with 5 ml of cold TCA (5% w/w) and twice with 2 nil of
cold ethanol. The mono layers were then allowed to dry and
the cells dissolved in 0.5 ml of 0.5 N NaOH. Radioactivity
was counted using gel scintillation mixture.
230 Treatment of infected or non-infected cells with
65-709, guanidine or cycloheximide
I.e.I. 65-709 was most easily dissolved in dimethyl-
sulphoxide at a concentration of 1 mg / m l., Before use it
was diluted 10 times in sterile distilled water ~a
concentration of 100 I-Lg/m!.
Guanidine and cycloheximide solutions were made in
water at concentrations of 2 mg / ml and 15 mg / ml
respectively and subsequently sterilised.
When either of the above compounds was to be used,
they were added to the maintenance medium for the necessary
period of time. When the effect of either of the above
compounds was to be reversed, the maintenance medium
which contained the compound was removed from the cells
and the monolayers were then washed twice with maintenance
medium and finally incubation resumed with prewarmed
medium.
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INTRODUCTION
Virus induced RNA species
The small RNA containing phages were discovered
in the early 1960ls (Loeb & Zinder, 1961; Straus & Sins-
heimer, 1963; Parenchych & Graham, 1962). The terhniques
already developed with T-phages and the ease of working
with bacterial systems are the major reasons why RNA has
been better studied with RNA phages. Evidence which
established that RNA replicates independently of the host
cell's genetic material was provided by Doi and Spiegel-
man (1962) who showed by hybridisation experiments the
absence of any homologous sequences between host DNA and
phage RNA. This was confirmed by experiments which showed
that viral RNA synthesis take~ place in the absence of
either host DNA synthesis (Cooper & Zinder, 1962; Simon,
1961) or DNA directed RNA synthesis (Reich et al., 1961).
The existence of an RNA-dependent RNA polymerase was first
detected in manunalian cells infected with mengovirus
(Baltimore & Franklin, 1962) and poliovirus (Baltimore
et al., 1963). However final proof of the nature and
function of the enzyme require it··to·-bepurified. This has
proved to be very difficult with animal virus systems
because the enzyme is intimately associated with membranes
(Horton et al., 1966; Friedman & Berezesky, 1967; Arling-
haus & Polatnick, 1967). However the purification of EMC
virus induced polymerase in BHK 21 cells has been recently
claimed (Rosen berg et al., 1972).
The fact that the replication of the single
stranded DNA phage ¢ x 174 involved a double stranded DNA
replicative form (Sinsheimer et al., 1962) led to the
search for such replicative forms induced by RNA viruses.
Montagnier & Sanders (1963) detected a 20S infective RNA
in Krebs II ascites tumor cells infected with EMC virus
which by criteria, such as ribonuclease resistance,
solubility in NaCl, buoyant density in CsS04, thermal
transition and sedimentation behaviour, established its
40
hydrogen bonded double helical structure. It was called
replicative form (RF) in analogy with the ¢ x 174 repli-
cative form. Baltimore et al. (196~) and Pons (1964)
reported"a double stranded RNA in BeLa cells infected with
poliovirus. The finding that more than one species of RNA
existed in infected cells was confirmed with other picorna-
viruses such as FMDV (Brown & Cartwright, 1964), ME virus
(Hausen, 1965), mengovirus (Plagemann & Swim, 1966), bovine
enterovirus (Clements & Martin, 1971), arboviruses such as
Semliki forest virus (Sonnabend. et al., 1964; Friedman &
Sonnabend, 1965), plant viruses (Burdon et al., 1964;
Mandel et al., 1964) and RNA phages (Ammann et al., 1964;
Fenwick et al., 1964; Kaerner & Hoffmann-Berling, 1964;
Kelly et al., 1965). It was realised soon after that
while the RNase resistant material was sedimenting as a
broad peak in sucrose gradients (extending between 14s and
30S) a sharp peak of RNA of around 16s was observed after
treatment with RNase (Erikson et al., 1965). This behaviour
led to the suggestion that another virus specific RNA
might be present in the infected cells which after RNase
treatment could yield material indistinguishable from RF
(ErikRon et al., 1965). It was also found that if cells
infected with bacteriophage R-17 were exposed to a radio-
active RNA precursor for a very short period of time, all
the radioactive label is found in this heterogeneous,
partially RNase resistant RNA. It was therefore called
replicative intermediate (RI), (Erikson et al., 1964) and
the proposal was made that these molecules consisted of
a double stranded core to which was attached RNase-
sensitive nascent single stranded RNA of variable size
(Fenwick et al., 1964).
The existence of replicative intermediate was
soon confirmed in cells infected with other bacterial
viruses and discovered in cells infected with a number of
animal viruses (Baltimore & Girard, 1966; Brown & Cartwright,
1964; Clements & Martin, 1971; Friedman, 1968). Both RF
and RI have been purified using NaCI and LiCl precipitation
{Montagnier & Sanders, 1963; Baltimore, 1966; Baltimore, 196~,
41
various chromatographic methods (An@ann et al., 1964;
Bishop, 1966; Bishop & Koch, 1967; Franklin, 1966; Kelly &
Sinsheimer, 1967~'Pinck et al., 1968; Bishop & Koch, 1969;
)
Robertson et al., 1968) and by exclusion filtration through
agarose (Baltimore, 1968~ Erikson & Gordon, 1966). It
should be pointed out here that RF and RI induced by
picornaviruses are infectious (Baltimore, 1966; Baltimore,
1968~;Bishop, 1966; Bishop & Koch, 1967) in contrast to
the RF from phages and arboviruses (Pons, 1964; Franklin,
1966). Phage RI has low specific infectivity (Kelly &
Sinsheimer, 1967~. All three virus induced RNA species
were better.resolved when the polyacrylamide gel electro-
t.ec~q"41.
phoresisYbecame available (Loening, 1967).
As far as rhinovirus induced RNA species are
concerned the first reports appeared in the literature
while this work was in progress. Sethi and Schwerdt (1972)
analysed the RNA species synthesized in HeLa cells after
infection with rh;novirus type 20 by sucrose gradient
centrifugation. They detected the RF and single stranded
RNA species and suspectHd the existence of RI as a minor
shoulder at about 24-26So However the limitations of the
technique they used did not allow good resolution of the
three species. Yin and Knight (1972) obtained the three
RNA species from HeLa cells infected with rhinovirus type
2 using polyacrylamide gel electrophoresis; however the
emphasis of this report was on the rhinovirus induced RNA
polymerase with little attention to the RNA species
'induced in vivo.
Involvement of RF and RI in the replication cycle
The replication of RNA has been generally
considered as a two step reaction (a) the synthesis of the
template complementary to the infecting molecule catalyzed
presumably by an RNA-dependent RNA polymerase (Enzyme I)
and (b) the synthesis of the progeny strands from the
template catalyzed presumably by a second enzyme (Enzyme II).
Whether two different enzyme molecules or an enzyme with
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two functions are involved in the completion of this
reaction has not yet been established. The enzymatic
activity associated with the first reaction seems to be
virus coded since some animal virus (Burge & Pfefferkorn,
1967; Cooper et al., 1970) and phage (Lodish & Zinder,
1966) conditional lethal mutants lack this property. The
evidence for a discrete second step in the above reactions
comes from the fact that enzyme I mutants can carry out
the enzyme II reaction for a substantial period of time
under non-permissive conditions if enzyme I is first
synthesized under permissive conditions (Lodish & Zinder,
1966). Cooper et al. (1970) have also shown that different
temperature sensitive mutants of poliovirus are 0efective
in distinct functions o~ RNA synthesis. This is good
evidence for the presence of more than one enzymatic
activity in the production of poliovirus RNA. A similar
situation has been demonstrated for FMDV by the separation
of the two enzymatic activities (Arlinghaus & Polatnick,
1969; Arlinghaus et al., 1972). However the criticism that
the enzymatic reactions were studied with crude preparations
is always valid.
The question of the role of RI and RF in the
synthesis of RNA outlined above has been investigated by
many workers. Montagnier and Sanders' assumption (1963)
that RF itself could mediate the reaction is questionable.
An outline of a scheme for RNA replication was put forward
by Spiegelman et al. (1968). Initially, the input RNA
(plus strand) is transcribed to give a partially double
stranded replicative intermediate (RI) which is hydrogen
bonded with the transcript. The plus strand of the RI then
serves as template for the synthesis of minus strands and
gives rise to multi-stranded structures containing nascent
minus strands. These are the negative RI's. From the
negative RI, negative RNA strands are released. These are
converted to positive RI's which synthesize positive strands
in the same way as minus strands are synthesized.
In summary:
SS+ - RI -
The theory can be extended in the light of more recent
work to include RF which under normal conditions appears
to be as much an end product obtained from RI as is single
stranded RNA itself (Baltimore, 1968~iGirard, 1969).
However there is disagreement in this area since Feissman
et al. (1968), while agreeing with the general concept
deny that any of the RNA molecules are joined by hydrogen
bonding in the infected cell. They suggest that the
replicative intermediate is a loose complex consisting of
template, polymerase and nascent chains and that there is
no hydrogen bonding between complementary RNA moleculeso
They believe that hydrogen bonds and hence RF's are
created during the deproteinising extraction procedure.
Spiegelman's model is supported by the observations that
(a) it is possible to recover partially RNase resistant
RNA (RI) from phage-infected cells without the use of
phenol or detergents (Weissman et al., 1968) and (b) it is
possible to isolate RF from extracts of poliovirus infected
cells after treatment only with deoxycholate which is a
very mild detergent (Baltimore et al., 1964; Bishop et alo,
1965). However there is evidence to the contrary that
(a) the early product of the standard in vitro replicase
reaction possesses little if any double helical structure
prior to the removal of protein with denaturants (Feix et
al., 1967), (b) purified minus strands (Feix et al., 1968)
and denatured RF (weissman et alo, 1967) are efficient
templates in vitro while (c) neither intact RI nor RF can
serve as templates in vitro (Weissman et al., 1967; Feix
et al., 1968; Mills et aL, , 1966).
We have used a different approach to investigate
the existence of hydrogen bonding between RNA molecules in
the rhinovirus-HEL cell system. Treatment of disrupted
infected cells with ribonuclease will degrade all single
stranded RNA. Using this procedure, followed by RNA
extraction, we find unchanged amounts of RF present
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indicating that this structure is not an artefact of the
deproteinising extraction procedure.
Another point to be considered is whether
conservative or semi-conservative RNA replication occurs.
The existing data suggest that the majority of RNA is
replicated semi-conservatively (Kelly & Sinsheimer, 1967aj
Erikson, 1966; Kelly & Sinsheimer 1967b; Girard, 1969;
Billeter et al., 1966; Weissman et al., 1964a; Bishop et
al., 1969; Weissman et al., 1964b; Kelly et al., 1965;
Erikson et al., 1964; Lodish & Zinder, 1966). However the
evidence does not exclude conservative replication and
more recent data suggest that RNA is replicated by both
mechanisms (Kelly & Sinsheimer, 1967a; Kelly & Sinsheimer,
1967b; Bishop et al., 1969; Francke & Hofschneider, 1969).
Finally I shall consider the circular model of
repli.cation proposed by Brown and Martin (1965). The fact
that RNA extracted from cells infected with FMDV was
found to be larger than the virion RNA could not be
explained by any model in which the template is assumed to
be linear. It was pos t.u.ta ted , therefore, that the ingoing
virus RNA codes for a complementary minus strand which
takes up the configuration of a circle or is synthesized
as a circular structure. The polymerase rotates around
this structure synthesizing a long plus strand consisting
of repeated sequences of virion RNA. This long plus strand
is then chopped by an enzyme into pieces of approximately
the size of virion RNA. Only the strands with the correct
length are incorporated into virions. The possibility that
the observed differences between the sedimentation of
single stranded RNA extracted from infected cells and of
virion RNA could be attributed to different secondary
structures rather than difference in size was excluded by
treatment of the RNAls with dimethylsulphoxide (Wild et al.,
1968) or formaldehyde (Wild & Brown, 1970) prior to
sedimentation. Further evidence in support of the circular
replication model was provided by Clements and Martin
(1971) when they reported that the same differences
observed originally on the size of RNA induced by FMDV
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were found in BHK cells infected with bovine enterovirus.
In addition to this, they have shown that the size of the
majority of RNA species varied with time and that early in
infection longer RNA strands were synthesizedo
We were unable to confirm Clements and Martints
findings and found that the majority 0f single stranded
RNA in infected cells was the same size as virion RNA and
that there was no difference in size between the RNA
synthesized early and late in infection. However a small
fraction of single stranded RNA may have been heterogeneous
in size and further investigation to establish the role,
if any, of this RNA is necessary.
An interesting and unexpected finding which
arose during this study. of RNA replication was the different
kinetics of synthesis of viral RNA which depended on the
cell in which the virus was growno This finding will be
reported and discussed further belowo
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Fig. 7. Multiplication of rhinovirus in HEL cells
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RESULTS
Ao General aspects of vil'us multiplication.
10 Virus.growth in human embryo lung (HEL) cells
Confluent mono layers of HEL cells in small
plastic petri dishes were inoculated with virus at
multiplicity of 5 to 10 p.f.u./cell. The virus was allowed
to adsorb for 90 min at JJoC and the residual virus was
removed by washing the cell sheets three times with
maintainance medium. The cells were then incubated at JJoC
with 2 ml of the same medium. At the intervals indicated
in Figo 7 the cells were observed in the microscope for
cytopathic effects (c.p.e.) and at the same times samples
were collected for titration of total and cell associated
virus as follows:
a. For total virus, the cells were scraped into the
culture fluid and frozen and thawed to release cell
associated virus. After clarification at 1000g the fluids
were titrated for infectivity.
b. For released virus, the culture fluids were
titrated for infectivity.
Fig. 7 shows the two growth curves. Infectious
virus was first detected at 4 h poi. after which it
increased exponentially until a plateau was reached at 11 ho
Over 90% of the virus remained cell associatedo These
conditions of virus growth were used in the following
experiments on the synthesis of viral RNA.
2. Virus-induced RNA species
RNA was extracted from cells labelled with
(3H)-uridine from 5-7 h p.i. and analysed by polyacrylamide
gel electrophoresis (Fig. Ba). Three major RNA species were
identified which were absent from extracts of uninfected
cells (Fig. Bb },
The fastest (I) had a mobility identical with
that for virus RNA (see Fig. 9) and migrated to a position
between the 28S ribosomal RNA and a "marker" of cellular
DNA which was frequently observed in the optical density
trace. The species of intermediate mobility (II) migrated
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Fig. 9. Co-electrophoresis of RNA extracted from HEL cells
labelled with [14cJ-uridine (0---0) from 9 to 11 h after
infection and virus RNA labelled with [3H]-uridine ( ).
The continuous line is the optical density trace at 260 nm,
indicating the position of the 288 ribosomal RNA and the marker
DNA.
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Fig. 10. Electrophoresis of RNAextracted from infected
HELcells labelled with l3H]-uridine from 5 to 7 h after
infection (e '0); untreated RNA; (0---0), RNA treated
,,,ith RNase (001 ~g/ml) •
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of the 28 S-V'ribosomal RNAs and the marker DNAo
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close to the DNA marker, and the slowest (III) entered
the gel to a variable extent.
Treatment of the extract with DNase before
electrophoresis did not alter the position of any of the
virus RNA. species and served only to remove the peak of
cellular DNA referred to above •
.3. Electrophoresis of virion RNA together with RNA extracted
from infected cells.
RNA was extracted from purified virions labelled
with [3H]-uridine. The RNA extracted from infected HEL
cells was labelled with [14e)-uridine from 9 to 11 hours
after infection. A mixture of the two was analysed by
polyacrylamide gel electrophoresis (Fig. 9). The fastest
migrating RNA from the cell extracts (Peak I) migrated
exactly to the same position as the peak obtained from the
pur Lf Led virions indicating that peak I contributes RNA to
infectious progeny virus particles.
4. Ribonuclease resistance of virus RNA.
Information on the structure of the virus RNA
species was obtained by RNase treatment. RNA extracted
from infected cells was dissolved in 2 x sse and
incubated with 0.1~g/ml RNase. Electrophoresis of the RNase-
treated extract showed that the fastest and slowest peaks
had been degraded, while the middle peak had increased in
size (Fig. 10 and Table 2).
PH] RNA cpm
Treatment Multi-stranded Double stranded Single stranded
None 254 (100}6) 76 (100}6) 938 (100}6)
0.11-Lg 47 (19%) 164 (216%) 0 ( 0%)RNase/ml
Table 2. Treatment with RNase of rhinovirus RNA from
infected cells.
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Fig. 11. Synthesis of virus RNA in HEL cells. Cells
were labelled with [3HJ-uridine continuously for the
times indicated and harvested immediately. The ar-r-ows
indic3.te 28S ribosomal RNA.
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Fig. 12. Course of synthesis of virus RNA. Each point
represents the total [3H]-uridine incorporated into
a species of RNA pulsed continuously up to the times
indicated. Only radioisotope above the background
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Fig. 13. Co-electrophoresis of nucleolar RNA extracted
from HeLa cells labelled with [3HJ-uridine (0 0) and
viral RNA extracted :from in:fected HEL cells labelled
wj.th [14cJ -uridine from 9 to 11 h after infection (0--0).
Inset: The distance migrated by each RNA species is
plotted on the abscissa against the log. of its molecular
weight.
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The latter RNase resistant peak was therefore designated
as double stranded (DS) RNA. The fast-moving peak was
RNase sensitive and migrated to the same position as
virion RNA and was designated single stranded (SS) RNA.
Since the slowest moving peak was hetero-disperse and
appeared to be degraded by RNase treatment into double
stranded RNA it was designated as multi-stranded RNA (MS)o
5. Time course of the synthesis of virus RNA'so
RNA was extracted from cells labelled
continuously with t3H]-uridine during the multiplication
cycle, and analysed by ele~trophoresis on polyacrylamide
gel (Fig. 11). The mean radioactivity above background in
peaks of MS, DS and SS ~A was calculated and normalized
by reference to the optical density of the ribosomal RNA
present in each preparation (Fig. 12). Radioactivity at
the origin suggested that MS could be detected at 3 h
after infection, DS was not detected until 5 h and SS
RNA until 7 h. MS and DS increased exponentially from 3 h
and SS RNA from 5 h up to the end of the exper-Lmerrt at
13 h. This was surprising since by 11 h, the production
of infective virus particles had reached a plateau and
the majority of cells sh0wed cytopathic effects.
6.,Estimation of the molecular weight of the SS viral
RNA by coelectrophoresis with nucleolar RNA as markero
t3H)-uridine labelled nucleolar RNA extracted
from HeLa cells was coelectrophoresed together with RNA
extracted from infected cells which were labelled withr4c]-uridine between 9-11 h p.i •• The molecular weights
of six of the nucleolar RNA species had been previously
666determined: these were 4.1 x 10 , 3.1 x 10 t 201 x 10
and 1.4 x 106 for the 45S, 41S. 32S and 24s respectively
(Weinberg & Penman, 1970), and 1.65 x 106 and 0.65 x 106
for the 28S and 18S ribosomal RNA's (Petermann & Pavlovec,
1966). In agreement with Loening (1969) the migration of
the marker RNA's was proportional to the log10 molecular
weight (Fig. 13, inset). The viral SS RNA migrated between
r
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Fig. 14. Co-electrophoresis of RNA from cells
infected with rhinovirus or with poliovirus.
Both were labelled with uridine from 9 to 11 h
after infection. The rhinovirus RNA was [14C]
, labelled (0--0) and poliovirus RNA [3H)labelled
~ .). The continuous line is the trace at
ODZ60•
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the 41S and 32S marker RNA (Fig. 13) and was calculated
to have molecular weight of 2.8 x 106 daltons.
7. Comparison of SS viral RNA from HEL cells infected with
rhinovirus or with poliovirus.
By sedimentation, native or denatured polio-
virus type 1 RNA is found to be larger than rhinovirus RNA
(Nair & Lonberg-Holm, 1971; Sethi & Schwerdt, 1972) but
these RNA's have not been compared by polyacrylamide gel
electrophoresis.
Parallel cultures of HEL cells were infected
with rhinovirus or poliovirus at a multiplicity of 10
pof.u./cell. The rate of growth of both viruses was
similar as judged by the appearance of cytopathic effects.
Both cultures were labelled from 9 to 11 h poi.; the
culture infected with rhinovirus was labelled with [14cJ_
uridine and that infected with poliovirus with [3H]-uridine.
RNA extracts were electrophoresed together (Figo 14)0
Rhinovirus single stranded RNA was clearly larger than
that of poliovirus, The MW of rhinovirus RNA was estimated
6as 2.8 x 10 , by reference to ribosomal RNA's (MW's of
0.67 x 106 and 1.64 x 106: Petermann & Pavlovec, 1966)
6and to poliovirus RNA (M\v 2.6 x 10 , Tannock et al., 1970;
Granboulan & Girard, 1969).
The same results were obtained when the
experiment was repeated with the isotopes reversed (i.eo
with rhinovirus l3H]-uridine labelled RNA and poliovirusr4C)-uridine labelJed RNA).
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Fig. 15. Multiplication of virus in HeLa cells
compared with that in HEL cells. The total yield
of cell-associated and released infectivity is
presented. The virus caused a cytopathic effect
which spread f'rom about 10% of' cells (±) to over
80% (+++).
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Pulse time
(h) MS DS SS
1 - 3 1 .7 0.8 0
3 - 5 1 a 8 005 0
5 - 7 1 92 1 .3 5.6
7 - 9 10.0 10.5 47.8
9 - 11 10.6 1502 73.4
11 - 13 11 .7 3702" 135.5
Table 3. Synthesis of rhinovirus RNA in HEL cells.
The radioactivity under each peak was
calculated and normalised with respect to
the 28S ribosomal marker. Data from Fig.
16.
Pulse time
(h) MS DS SS
5 - 7 10.0 903 80.8
7 - 9 6.1 12.7 81 .2
9 - 11 2.5 13.9 83.6
Table 4. Percentage of total rhinovirus RNA
synthesized as multi-stranded (MS), double
stranded (DS) or single stranded (SS)
species during infection of HEL cells.
B. Virus multiplication and RNA replication in diploid
and heteroploid cells.
The study of the time course of synthesis of
viral RNA in HEL cells was reported in section A5. The
observation that viral RNA synthesis increased exponentially
even after the virion production reached a plateau, led us
to the following experiments.
1. Virus multiplication in BEL and HeLa cells.
The growth of the virus was followed in both
HEL and HeLa cells. The two growth curves were obtained
under identical conditions described in section A1. The
two growth curves were bssentially similar (Fig. 15) and
in both systems the virion production reached a plateau
at about 11 h after infection.
2. viral RNA replication in diploid and hete~ploid cells.
In the experiment of section A5 the (3H]-uridine
was present continuously during the replication cycle
because the aim- of that experiment was to obtain
information on the appearance and accumulation of the 3
viral RNA species. In the two following experiments cells
were pulsed with l3H)-uridine for consecutive intervals
of 2 h to enable us to determine the peak of viral RNA
synthesis in both HEL and HeLa cells
a. Replication in HEL cells.
The RNA from infected HEL cells pulsed with
pH]-uridine for consecutive intervals of 2 hours was
extracted and analysed by polyacrylamide gel electrophor-
esis (Fig. 16). The arpa of radioactivity in peaks of
virus RNA was calculated and normalized as described
earlier (Table 3). Synthesis of virus RNA was first
detected during the 5 - 7 h pulse. DS and SS RNA continued
to increase exponentially even during the last pulse from
11 to 13 h. The synthesis of MS RNA increased until the
7 - 9 h pulse and then remained constant.
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Fig. 17. Electrophoresis of virus RNA synthesised in
HeLa cellso The continuous line is the OD260 trace,
indicating the position of the 28S ribosomal RNA
and the 'marker' DNA.
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Pulse time
(h) MS DS SS
3 - 5 100.0 0 0
5 - 7 1.4 1508 125 .l~
7 - 9 7.1 139.0 618.1
9 - 11 9.9 14700 561 .9
11 - 13 l.j 3 .l~ 90.9 523.8
13 - 15 3.3 57.8 91.5
Table 5. Synthesis of rhinovirus RNA in HeLa cells.
The radioactivity under each peak was
calculated and normalised with respect to
the 28S ribosomal RNA. Data from Fig. 18.
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Fig. 18. Time course of synthesis of viral SS RNA in
HEL(O---O) mid HeLa (~) cells. Each point represents
the middle of a 2 h pulse of [3H]-uridine and is the
normalised sum of radioactiv1ty under each peako Data
is taken from Tables 3 and 5.
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Fig. 19. Time course of sJ~thesis of viral DS RNA in
BEL (0-0) and HeLa (0 e) cells.· Each point represents
the middle of' a 2 h pulse of'[ JH] -uridine and is the
normalised sum of'radioactivity under each peak. Data
is taken f'rom Tables J and 5.
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Pulse time TCA - precipitable
(h) cpm
Non-infected 1,600
3 - 5 4,600
5 - 7 55,000
7 - 9 13,000
9 - 11 10,000
Table 6. Synthesis of rhinovirus RNA in L132 cellso
The total TCA-precipitable counts are
presentedo
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Over a large number of experiments using
different concen~rations of (3H)-uridine, different
batches of virus and cells of different passage number,
the proportion of each RNA species expressed as a percent-
age of the sum of the species was remarkably constant
(Table 4). The predominant species was SS RNAo From its
first appearance until late in infection, SS RNA comprised
approximately 80% of the total. DS RNA remained cunstant
at about 10% while the percentage of MS RNA declined from
10 to 2.5%.
bo Replication in Hel~ cells.
This experimpnt was done in parallel with the
experiment described above in which HEL cells were usedo
Fig. 17 shows the analysis of viral RNA's e~tracted from
infected HeLa cells pulsed for consecutive periods of 2 ho
The radioactivity in peaks of virus RNA was calculated and
normalized as described earlier (Table 5).
The results from tables 3 and 5 were plotted
separately for SS and DS RNA as they appear with the time
after infection (Fig. 18, 19). The important point from
these graphs is that, in contrast to the situation in HEL
cells, the synthesis of the viral RNA in HeLa cells
reached a plateau at 8 h after infection and later on
declined.
c. Replication in L132 cells.
In this experiment viral RNA synthesis was
measured in infected L132 cells, which is another hetero-
ploid human cell line, as a function of the time after
infection. The infected cells were pulsed with (3H]-uridine
for consecutive 2 h intervals, in the presence of AMD and
were assayed for TeA-insoluble material (Table 6). Viral
RNA which was first detected during the 3 - 5 h pulse
increased until the 5 - 7 h pulse and then declined.
In conclusion the kinetics of rhinovirus RNA
synthesis in heteroploid cells is different from those in
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diploid cells.
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Fig. 200 Electrophoresis of RNA extracted from infected
HEL cells which were pulsed with [3H]-uridine for 3,10,
20, 40, 60 and 120 min.
C'l \0 C\I T"" ..... \0
~ • I' • • I' I'
C\I r- co T"" If'\ \0
C\I C'l ..::t" If'\ r-
UJ
UJ
El C'l C\I \0 C'l C\I 0\
o, • • p • · I'o 0 C'l C\I ..::t" If'\ \0
T"" C\I \0 £'.. 0\
..::t"
£'.. C'l CO ..::t" C'l COv. • • I' I' • 0
0\ ..::t" 0\ C'l ':""" If'\
C'l C\I C'l C'l T""
UJ
Cl
El C'l ..::t" \0 C'l CO 0\c, • 0 • I' 0 •o ..... \0 r- C\I C\I C\I
T"" T"" If'\ ..::t" 0
T""
-
0 T"" 0 If'\ \0 \0
~ 0 • 0 • • .
CO CO C\I If'\ C'l £'..
CO C'l C'l C\I T""
UJ
~
El r- C\I 0\ 0\ £'.. If'\p., • 0 0 I' • 0
0 T"" CO CO 0\ CO 0\
, T"" T"" T"" C'l T"" ..::t"
rl 0 0 0 0 0 0
ro v. 0 0 0 0 0 0
H T"" T"" T"" T"" T"" T""'H
> <
,..:j ~
(Ij El C'l CO T"" If'\ £'.. C'l
..j.) p., • 0 • • • •
0 0 C'l £'.. 0\ \0 \0 0\
8 T"" ..::t" If'\ If'\ C'l ..::t"
T"" T"" \0
~
Cl> 0
m 'H ~
.-I ..j.) 'H C'l 0 0 0 0 0
~ ro El T"" C\I ..::t" \0 C\I
~ S T""
'Cl
Q)
..c:
..j.) H
Cl>
'H '20
~
~ :>.0'H ..j.)
..j.) 'H
ro :>
H 'H
~ ..j.)
"0 0roO
Q) 0..c: 'H
..j.)
~
tto H
~'H "0
m Q)
ro m
Q) 'H
H .-Io
~~'H H
0
:>. ~
.0
Cl>
"0 ..c:
Q) ..j.)
..j.)
c ..j.)
Cl> ~
..j.) Cl>e m
'(i Cl>
H
m o,
ro Cl>
H
m
.-I m
.-I Q)
(I) ao
H 'M
~
'H
Cl>
~ ..c:'H 8 I'
0
m • C\I'H (I)
m m •
(I) .-I b.O..c: ~ 'H
..j.) p., ~
~ (I) ~
m ~ 'H'H< "0 ..\!:
~
'H ro
S (I)p.,
rl ,
ro ,....., ..c:
H ~ ()'H C'l ropo ~ Cl>
•
£'..
Q)
.-I
.g
8
..,,.,
1-'
c. The role of the three viral RNA species in repli,cation.
According to their electrophoretic mobility and
RNase sensitivity the three species of virus RNA in
infected cells were designated MS, DS and SS RNAo In this
section experiments will be described which investigate the
relationship between MS, DS and SS RNA during replication,
H-bonding between strands in MS and DS RNA and the circular
model of replicationo
1. Short [3H)-uridine pulses.
Fenwick et al. (1964) first used short uridine
pulses in order to elucidate the active intermediate(s) of
RNA replicationo Theoretically if [3H)-uridine is present
in the infected cells for shorter time than the time
required for the synthesis of a new strand of RNA, then
all label is expected to be located in the active
replicative intermediate of the replication process~
Infected HEL cells we.re pulsed w.L th [3H]-uridine
from 3 to 60 mins as indicated in Fig. 20. The pulses were
all terminated at 11 h and RNA was extracted and analysed
by polyacrylamide gel elect~horesis (Fig. 20). During
the shortest pulse (3 min) all label above background is
found in the position to which MS RNA usually migrates.
After the 10 min pulse, MS RNA is still the predominant
species although DS and SS RNA are easily recogniAed. The
,percentage of radioactivity in the peaks of MS, DS and SS
RNA was calculated from the sum of normalized radioactivity
in each peak (Table 7)0 MS RNA, which is the main species
after the shorte~pulse (88% of the total RNA) decreased
gradually as the labelling period was increased (only
7.6% for the 120 min pulse). DS RNA which was 9.7% of the
total viral RNA after the 3 min pulse increased to a
constant value of 30% in the longer pulses and dropped
down again to 15% after the 120 min pulse. The SS RNA
increased constantly with the duration of the pulse, from
2.3% after the 3 min to 76.6% after the 120 min pulse.
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Fig. 21. Electrophoresis of RNA extracted from
infected HEL cellso Cells were labelled for 5 min
wi th 10 !-Lc/ ml of [3HJ -uridine; at the end of'
this period they received a 106-fold excess of
cold uridine and the RNA was extracted under
standard conditions at the indicated times.
Continuous l.ine represents the OD260 trace
indicating the position of the 288 ribosomal RNA
and the 'marker' DNA.
Time after I
chase MS ns SS.
(min)
, 0 6506 501 8.0
10 50.0 1006 3607
20 40.8 15.5 31 04
40 30.1 41 01 234.3
Table 8. Radioactivity found in viral RNA speoies at
the indicated times after the addition of
cold uridine. The figures represent the
normalised radioactivity under each peak in
Fig. 21.
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Fig. 22. (a) Chase of viral RNA in vivo uy
addition of excess of cold uridine. Data
obtained frcm Fig. 21. (~) RI, (. .) RF,
(0-0) SS RNA.
Fig. 22 (b) is reproduced from r.lcDonnelland
Levintow (1970) and illustrates the distribution
of the label betweerrthe 3 poliovirus RNA species
after chase.
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Fig. 23. Treatment of disrupted infected cells with
ribonuclease before extraction of RNA. Infected HEL
cells were labelled with [3H]-uridine from 9 to 11 h
after infection and the extracted RNA was analysed
by electrophoresis. (a) control, (b) and (c) treated
with 0.1 and 10 t-Lg/ ml of RNase respectively. The
continuous line is the OD260 trace indicating the
position of the 'marker' DNA and the ribosomal RNA
in the control figure.
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2. Chase of [3H1-uridine labelled viral R.NA by cold uridine.
Using HEL cells we have shown that it is
possible to chase (3HJ-uridine with an excess of cold
uridine (see "Methods"). Using the same conditions we have
attempted to investigate the relationship between MS, DS
and SS RNA during replication.
At 9 h after lni'ection HEL cells were labelled
for 5 mins with 10~c/ml of [3H]-uridine. At the end of this
6period the cells received a 10 -fold excess of cold uridine
and the RNA was extracted at various times after chase
(Fig. 21). The radioactivity in each RNA species was
calculated and normalized (Table 8). Initially the major
species was the MS RNA. During the 40 min chase the MS RNA
decreased 2-fold while the DS and SS RNA increased 8-fold
(Fis· 21a..)
and 30-fold respectivelyk This is in close agreement with
the data obtained from the in vitro chase of poliovirus
RNA synthesis by McDonnell & Levintow (1970) from where
the Fig. 2lb was' obtained for comparison.
3. Hydrogen bonded RNA in replication.
The aim of this experiment is to demonstrate
directly whether H-bonding between RNA molecules is an
integral part of the replication process (Spiegelman et al.,
1968) or artefact resulting from the extraction procedure
(Weissman et al., 1968).
Infected HEL cells were labelled with [3H]_
uridine between 9 - 11 h p.i •• The cells were then washed
twice with cold extraction buffer and 2 ml of 2 x SSC
were added to cover the cell sheet. The monolayer was
scraped into the SSC solution and the cells disrupted by
freezing and thawing. At this point the cell extracts
were divided into three parts, two of which were treated
with RNase (0.1 and 10~g/ml) for 10 min at 37°C. RNA was
then extracted from the three samples using our routine
phenol-SDS extraction method and was analysed by poly-
acrylamide gel electrophoresis (Fig. 23).
Complete degradation of the SS RNA species,
350
300
I
- 250
200 ~z
Cl. 2:
u Cl.150 u
400
100
200
Fractions
.
Fig. 21~. Co-electrophoresis of RNA from rhinQvirus-
infected HEL cells la.belled from 5 to 7 h w i,th [3H]_
uridine (&--41) or from 9 to 11 h 'vith (14c 1-uridine
(0--0). The continuous line is the OD260 trace,
indicating the position of 283 ribosomal RNA and the
marker DNA.
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both viral and ribosomal occurred after ribonuclease
treatment at either concentration of the enzyme. The MS
RNA was partially dograded with O.1~g/ml of RNase and was
totally ~egraded when the concentration of RNase was
increased to 10~g/mlo The DS RNA remained intuct after
such treatment indicating that hydrogen bonding was
present in the preparation before the phenol extractiono
4. Size of SS RNA synthesized early and late in infection.
Evidence has been provided that early in
infection some picornaviruses synthesize SS RNA which is
larger than the RNA of the virion (Bro,~ & Martin, 1965;
Clements & Martin, 1971). With this evidence these authors
proposed a 'rolling-circle' model for the synthesis of
picornavirus RNA. Since this matter is fundamental to
theories of RNA replication we examined the size of SS RNA
synthesized by rhinovirus and by the bovine enterovirus
used by Clements & Martin (1971).
(a) Rhinovirus in HEL cells
Rhinovirus RNA was labelled at 5 to 7 and at
9 to 11 h postinfection with (3H)_ or l14C]-uridine,
respectively and analysed by electrophoresis on a single
polyacrylamide gel (Fig. 24). The SS RNA labelled at
either time migrated to the same position in the gel and
in peaks of similar width.
(b) Bovine enterovirus in flliLcells
In HEL c~lls the exponential production of
virions ended at 7 h after infection. Accordingly, RNA
was labelled from 0.5 to 4 h and from 4 to 7 or 9 to 11 h
postinfection with [3H]_ or r4cl-uridin~ respectively.
Co-electrophoresis showed that SS RNA extracted at either
time migrated identically (Fig. 25a).
(c) ~ovine enterovirus in BHK cells
The occurrence of SS virus RNA larger than
virus particle RNA has only been reported in BHK cel1so
Since we failed to find such RNA in infected HEL cells
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Fig. 25. Co-·electrophoresis of RNAfrom bovine entero-
virus-infected cells (a) HELcells labelled fro~ 0.5
to 4 h with [1l~C] -uridine (e----0) or from 4 to 7 h
.with PH] -uridine (0--0). (b) Bille ce Ll.s labe Ll.ed from
0.5 to l~ hwith [31d-uridine (~) and from 4 to 6 h
with [14c] -uridine (0 0). The continuous line is the
optical de~sity trace at 260 nm.
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we examined the system described by Clements & Martin
(1971), that of BHK' cells infected with bovine enterovirus.
In BHK cells the exponential production of virus
particles started at J h and reached a plateau at 5 h after
infection. Accordingly, we labelled froru 0.5 to 4 hand
from 4 to 6 h after infection with [JHJ- or ~4c)-uridine,
respectively (Fig. 25b)o Co-electrophoresis showed that
the peaks of virus SS RNA coincided and had similar
distributions. SS RNA obtained when cells were labelled
from 0.5 to 2.5 h was also of the same size.
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DISCUSSION
Growth o~ rhinovirus in BEL cells
We have ~ound that BEL cells provide a
satis~actory system ~or studying rhinovirus multiplication,
although the diploid cells are less convenient to use
than continuous cell lines and more fastidious in their
growth requirements.
The growth of the virus in these cells is very
similar to that reported by stott and Heath (1970) in
suspensions of the ~ontinuous line o~ L132 cells
infected with the same virus. No virus is detected before
4 hours after infection. Virus then increases exponentially
until 11 h after infection when the plateau of virus
multiplication is reached.
A major advantage of the BEL cells was the
consistently higher yield of virus RNA relative to
cellular RNA. Viral RNA could be detected by optical
density at 260nm and WaS as much as 4% of the total
ribosomal RNA present in infected BEL cells.
Our work on the synthesis of viral RNA in HEL
cells indicated that the kinetics were different from
those in HeLa cells. The importance of this observation
in relation to transcriptional control, which might be
relevant to the diploid and heteroploid state of the cells,
is discussed below.
virus RNA species
We did not detect any RNA synthesis in non-
infected BEL cells treated for 3 h with 1~g/ml AMD.
The use of the polyacrylamide gel electrophoresis
technique, especially when the concentration of the
acrylamide was brought down to a minimum (1.7%) has been
proved to offer goou resolution of the various RNA species.
The results presented in this study clearly establish that
three RNA species are consistently found in HEL cells
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infected with rhinovirus type 2. This is in agreement
with the results obtained by Sethi and Schwerdt (1972)
who detected only double and single stranded RNA species
in HeLa cells infected with rhinovirus type 14. The
limited resolution by sucrose gradient centrifugation is
the obvious explanation for their failure to detect the
third RNA species. We are also in agreement with the
results reported by ,Yin and Knight (1972) who'resolved
by polyacrylamide gel elect~horesis the three RNA species
obtained from HeLa cells infected with rhinovirus type 2.
structure of the viral and virus induced RNA species
Pancreatic ribonuclease has been used to study
the structure of these-RNA species since it will attack
single more readily than double stranded regions of RNAo
We have worked out condition3 in which RNase would
selectively degrade only the SS RNA leaving the DS RNA
intact. In our experience the concentration of salt is
the critical factor for this selective degradation of
SS RNA.
In the experiment illustrated in fig. 10, it
is clearly ~hown that while the species with the fastest
wlectrophoretic mobility is RNase sensitive, the one with
intermediate mobility is RNase resistant. The third
species which did not form a discrete peak and migrated
only a short distance into the gel upon electrophoresis
was found to be degraded by RNase and this resulted in
an increase in the peak of the RNase resistant species
(Table 2).
This behaviour of the virus induced RNA species
on ribonuclease treatment is in agreement with the results
published by Baltimore (1968) for poliovirus and there-
fore we conclude that the three RNA species (in order of
electrophoretic mobility) are single stranded, double
stranded and the third consisted of a double stranded
core from which single strands are tailing off.
87
~ize of virion RNA
The molecular weight of the RNA of various
rhinovirus strains has been studied by a number of
workers. Only lately has agreement been reached that the
MW of the RNA of rhinoviruses is in th& region of 202
2.8 x 106 daltons. In 1968, McGregor and Mayor on the
basis of measurement of the length of a ribonucleoprotein
strand by electron microscopy estimated the MW of the RNA
o£ rhinovirus type 14 as 4 x 106 daltons. However thA
same workers in 1971 reported that "evidence suggests
that the association of a single stranded nucleic acid
with a protein can lead to errors in the estimation o£
molecular weight based on linear density" and reported
a value o£ 2.1 x 106 daltons based on hydrodyna~ic
methods and 2.2 x 106 daltons based on the sedimentation
o£ the RNA in sucrose gradients.
Our estimate o£ the MW o£ rhinovirus type 2 RNA
is 2.8 x 106 daltons. This is based on coelectrophoresis
with the precursors of the ribosomal RNA from HeLa cells.
The MW's of the ribosomal RNA's are well established
(Weinberg & Penman, 1970) and have been used for the
calibration of the polyacrylamide gels. The value of
2.8 x 106 daltons lies within the range of MW's reported
by several investigators (Brown et al., 1970; Nair &
Lonberg-Holm, 1971; Sethi & Schwerdt, 1972). It should
be pointed out that the value of 2.8 x 106 daltons has
been obtained after electrophoresis o£ native RNA. This
value must there£ore be regarded as a minimum estimate
since the absolute MW can only be measured after the
secondary structure has been destroyed. Fenwick (1968)
and Boedtker (1968) have showed that a more precise
relationship between sedimentation rate and MW for a
number o£ different RNA's could be obtained if the
con£igurational restraints are diminished by reacting
the RNA with formaldehyde. Boedtker (1971) has shown that
the MW's of QP and R17 phage RNA as measured by poly-
acrylamide gel electrophoresis are significantly larger
a£ter treatment with 1 .1M £ormaldehyde. Nevertheless
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Brown et al. (1970) and Nair and Lonberg-Holm (1971)
estimated the MW of rhinovirus type 2 RNA being within
6the MW range of 2.4 - 2.8 x 10 daltons after treatment
of the RNA with formaldehyde or dimethylsulphoxide.
Earlier reports have compared the 3ize of SS
RNA of rhinovirus with poliovirus: McGregor and Mayor
(1971), Nair and Lonberg-Holm (1971) and Sethi and Schwerdt
(1972) found that both native and denatured poliovirus
type 1 RNA sedimented faster on sucrose gradients than did
rhinovirus RNA from type 14, type 2 and type 20, respect-
ively. However our results frum·coelectrophoresis of
native RNA from cells infected with rhinovirus type 2 or
poliovirus type 1 showed that the rhinovirus SS RNA was
the larger. Clearly there is a discrepancy which indicates
that movement of these RNA molecules in sucrose gradients
or polyacrylamide gels cannot be determined solely by
the molecular weight of the RNA. Such an observation has
already been made with the "26s" RNA of Semliki Forest
virus, which by polyacrylamide electrophoresis is larger
than 28S ribosomal RNA (Kennedy, 1972).
Function of virus induced RNA species
The single stranded RNA extracted from infected
cells has an electrophoretic mobility identical to the
RNA found inside virions (Fig. 9). This, and by analogy
with the fact that the base ratio of the single stranded
RNA synt~esized in poliovirus-infected cells almost
matches that of virion RNA (Zimmerman et al., 1963), leads
us to the conclusion that the single stranded RNA found
in infected cells is the end product of the RNA
replication process and will be incorporated within the
virions during maturation. This conclusion is further
supported by experiments on the kinetics of RNA synthesis
which are discussed below.
When a labelled precursor of RNA is present
continuously in infected cells the amount of radioactivity
present in each of the RNA species observed at a given
time represents the resultant synthesis, degradation and
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interconversion. If we assume that the degradation of SS
RNA occurs to the same extent as the degradation of the
single tails of the MS RNA, then any observed difference
between -t he two species will be due to the conversion of
the species with the lower rate of increase to the other
with the higher rate. We have found that while the SS RNA
increased 1000-fold between 5 and 13 h after infection,
the multi-stranded species increased only 250 times
during the same period (Fig. 12). This is in agreement
with the postulated precursor-product relationship between
multi-stranded and single stranded species. No conclusion
is possible f'rom thi.s experiment as far as DS RNA is
concerned (which increased 500 times in the same period)
since the degradation pattern will be totally different.
The situation is further complicated since it is possible
that DS RNA is derived from MS RNA species.
Evidence that the MS RNA is the basic precursor
in replication is also shown by the [3H]-uridine short
pulse experiment (Fig. 20). After infected cells were
exposed to the radioactive RNA precursor f'or as little
as 3 min all the label was present in the region of'the
polyacrylamide gel in which the MS RNA runs. By increasing
the period of exposure, the label is found in increasing
amounts in the other species of RNA. These results are in
agreement with those of'Baltimore (196~) who f'ound that
after exposure of infected HeLa cells with poliovirus to
[JH]-uridine for 2.75 min 67% of the label was found in
the MS RNA. From this experiment two observations
regarding the DS kNA can be made: the initial synthesis
of DS RNA followed similar kinetics to the SS RNA a fact
which is against any intermediate role of' the DS RNA in
the replication process. However~later in infection DS RNA
is accumulated at a much slower rate than the SS RNA.
This is an indication that the DS RNA is not a consistent
by-product of the replication.
The conclusive evidence that MS RNA is the
intermediate of'the replication comes from the chase
experiment (Fig. 21).
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Baltimore, in his review article (1969), has
presented evidence that radioactive uridine cannot be
chased in mammalian cells with an excess of cold uridine.
He suggests that the intracellular uridine is phospho-
rylated and cannot escape from the cells, hence addition
of cold uridine therefore will not lower the amount of
radioactivity in the cellular pool of nucleotides.
Secondly, because the cell itself has a larger internal
pool of uridine nucleotides than the maximal amount of
uridine it is able to take up from the medium, the
nucleotide pool cannot be extensively diluted by adding
a large excess of cold uridine. Nierlich (1967) has
shown that exogenously supplied radioactive uracil enters
the intracellular pools of RNA precursors in Escherichia
coli only as nucleotides are removed from these pools by
net synthesis of RNA. He went on to show that the chase
of radioactive RNA precursor by an excess of cold
precursor was also impossible in procaryotic cells.
We have shown that the ability to chase uridine
in eukaryotic cells varies with the cell type and that it
is possible to do useful pulse chase experiments (Fig. 5).
Although it seems that this brings ourselves into a
controversial position with Baltimore we believe that
the difference lies i'l~ experimental conditions of the
chase. While Baltimore measured the radioactivity
incorporated into the RNA only shortly after the addition
of the cold uridine (his last sample was measured only 12
min after the chase was started) we extended this period
to 120 min. In the case of HEL or HeLa cells we have
shown that for the first 10 to 15 min the cold uridine
retarded but did not stop the incorporation of radio-
active uridine into the RNA. However, after the first
·10 min, virtually no more radioactivity is incorporated
into RNA. Of the cells tested only BHK cells followed the
kinetics predicted by Baltimore. Surprisingly enough we
found that chick embryo fibroblasts are the most suitable
cell type for chase experiments (Fig • .5). It can be argued
that chase with a delay of approximately 10 min could not
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be of any use. However the experiment illustrated in
Fig. 21 shows for the first time direct evidence on the
role of HS RNA in an animal virus system in vivo. Initially
label is present only in !'is RNA. After the addition of
cold uridine the label in HS RNA decreases and label in
SS and DS RNA increases. The kinetics are in fact similar
to those of the short-pulse experiment and again DS RNA
accumulated in the same manner in which it accumulated
in the pulse experiment. Therefore DS RNA has no inter-
mediate role in RNA replication.
The experiments discussed in this section
supply the evidence on the intermediate role of MS RNA
which can therefore be accurately designated as repli-
cative intermediate (Rl) (Erikson et al., 1964)0 These
experiments also supply the evidence that the SS RNA
found in the infected cells is the end product of the
replication process. The question wh.i.chremains unsolved
is the one concerning the DS RNA which has all the
characteristics of replicative form (RF) as described
for the other virus-cell systems (Bishop & Levintow,
1971). It has been suggested that RF might be an artefact
formed during extraction procedures (Weissman et al.,
1968). In fact, as has been mentioned in the introduction,
Weissman et al. believe that H-bonds between the RNA
molecules are only formed during extraction of the RNA.
We can exclude this possibility since we found that RF
was still present after all RNA single strands were
degraded with ribonuclease before the RNA was extracted
with phenol (Fig. 22). Although this experiment has
shown that H-bonding is not an artefact of the extraction,
we do not know if the RF remaining after RNase degradation
is real RF or degraded RI. This question could be
answered by selectively labelling RF without RI by
chaSing uridine from RI to RF (and SS RNA). If RF remains
after treating freeze-thawed cells with RNase followed
by phenol extraction, then we can conclude that RF is a
real entity in infected cells. A preparation containing
only RI can be obtained by labelling with a brief pulse.
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By treating this preparation with RNase in the same way
we shall be able to determine whether or not multi-
stranded RI has H-bonding between RNA molecules.
From the experiment in Fig. 22 we can determine
the proportion of SS RNA which has been inco~porated
into virions. Since the RNA in released virions is
resistant to RNase we can assume that the RNA in cell-
associated virions is similarly resistant. Therefore
the proportion of SS RNA remaining after RNase t.r-ea.t.merrt
of freeze-thawed cells represents encapsidated SS RNA
and the remainder is not in ma tur-evirions 0 Thus 4% RNA
is encapsidated and 96% is not.
Virus multiplication aiLdRNA replication in diploid and
heteroploid cells
The dynamics of synthesis of the three species
of rhinovirus RNA in HEL cells are of interest since
some aspects of these results are different from those
obtained by other investigators working with similar
systems. Sethi and Sch,,'erdt(1972) found that the
exponential increase of viral RNA synthesis in HeLa cells
infected with rhinovirus type 2 is not maintained late
in infection. Noble and Levintow (1970) have also
reported a similar decline in RNA synthesis in HeLa cells
infected with poliovirus. The experiments described in
section B of this chapter demonstrate that although
the multiplication of the virus is very similar in the
two cell types (Fig. 15), different levels of viral RNA
are observed late after infection. In HeLa and L132
cells the levels of viral RNA reached a maximum and
then declined (Fig. 18, 19 and Tables 4, 5, 6) with
kinetics very similar to those observed for the
replication of poliovirus in HeLa cells (Noble &
Levintow, 1970). However in HEL cells the levels of viral
RNA continued to increase for at least 4 hours longer
than in HeLa or L132 cells (Fig. 18, 19 and Tables 4, 5,
6). Since the pool of acid soluble uridine in HeLa cells
has been shown to be constant (Fig. 4b) even when the
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levels of viral RNA decline, the explanation of the
different levels of viral RNA in diploid and hetero-
ploid cells could possibly be the result of different
cellular control of the replication of virus RNA. Control
may be exerted by the action of ribonucleases, the low
levels of viral RNA observed late after infection in
HeLa cells being due to increased RNase activity. However
we consider this to be an unlikely explanation since
the change in viral RNA levels is shown in both singJe
and double stranded RNA and it is unlikely that the
nucleases degrade both types of nucleic acid with
equal efficiency. If the difference obtained with diploid
and heteroploid cells is not due to degradation of RNA
by nucleases, then it may be due to different r~tes of
viral RNA synthesis. It has been suggested recently
that the enzyme responsible for the viral RNA synthesis
(RNA-dependent RNA polymerase) in virus-infected cells
contains virus modified cellular polypeptides (Rosenberg
et al., 1972). It is also known that picornaviruses
inhibit cellular protein synthesis and that the viral
polymerase is unstable. Therefore if the continued
synthesis of cellular protein synthesis is required it
is possible that the rate at which the virus inhibits
cellular protein synthesis could control the rate at
which viral RNA polymerase synthesis and hence RNA
synthesis can continue.
'Circular model of replication
We have shown that cells infected with rhino-
virus type 2 synthesize a species of SS RNA which has
an electrophoretic mobility identical to that of virion
RNA (Fig. 9). The details of synthesis are not known
but evidently it is a closely regulated process since
SS RNA molecules synthesized in infected cells during
exponential increase of virus and during the plateau of
Virus production showed no detectable variation in size
(Fig. 24). This feature is of particular interest since
other picornaviruses, foot-and-mouth disease virus
(Brown & Martin, 1965; Wild & Brown, 1970) and bovine
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enterovirus (Clements & Martin, 1971), are reported to
synthesize RNA of different molecular weights at different
times during the multiplication cycle. We have repeated
these experiments with bovine enterovirus and found that
SS RNA synthesized in HEL or BHK cells at different
stages of the multiplication cycle also showed no
detectable variation in size (Fig. 25). It is still
possible to argue that molecules of SS RNA larger than
virion RNA were present in small amounts in the rhino-
Virus, bovine enterovirus or poliovirus infected cells
represented in the electrophoretograms above. Such
small amounts would be difficult to distinguish from
the background scatter of radioactivity. The limited
number of such molecules would only be found on our
experimental conditions if the labelling of SS RNA of
the same size as virion RNA wa s f'avour-ed, We conclude
that our data provide no evidence to support the
"rolling - circle" hypothesis for picornavirus RNA
replication and do not conclusively disprove it.
However the hypothesis of a circular model of r~plication
is support~d by the findings of other investigators.
Agol et alo (1972), using electron microscopy of
purified preparations of the RF of EMC virus found three
categories of molecules which were of linear, of circular
and of unknown structure. On the basis of electron
microscopy they have calculated the MW of these circular
structures to be 5.25 ~ 0.28 x 106 daltons. This value
is expected to be twice as much as the MW of the SS RNA
of the same virus. Indeed the MW of SS RNL of EMC has
been calculated by an independent method to be 2.7 x 106
daltons (Burness & Clothier, 1970).
Yogo and Wimmer (1973) have found that while
the 3'-end of the plus strand of the RF of poliovirus
RNA contains a polyA region, which is longer than the
corresponding region of the virion RNA, the complementary
(minus) strand contains the polyU region at the
3'~erminus. An explanation of this finding might be
that the poliovirus RF forms circles since its single
stranded 3'-termini are complementary to each other,
RESULTS . PART II
"Effect of the antiviral compound ICI 65,709 on
viral RNA synthesis."
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INTRODUCTION
Several natural or synthetic selective inhibitors of
picornavirus multiplication have been described during
the last 15 years. The term selective inhibitor is
generally employed to characteriza inhibitors which
display antiviral activity in concentrations much lower
than those producing harmful effects to host cells.
The best studied inhibitors are of'both biological
and synthetic origin. The f' Lrs t class includes the
inhibitors contained in bovine sera (Takemori et al.,
1957; Takemori et alo, 1958), normal horse sera (Takemoto
& Habel, 1959) and dextran sulphate (Rightsel et al.,
1961); they are of'large molecular size and act on an
early stage of'cell-virus interaction. Among the
synthetic inhibitors guanidine (Rightsel et al., 1961;
Loddo, 1961; Uecla et aL, , 1961), 2 - (a - hydroxybenzyl) -
benzimidazole (HBB) (Hollinshead & Smith, 1958; Tamm
et al., 1961; Eggers & Tamm, 1961a; Eggers & Tamm, 1961b)
and gliotoxin (Rightsel et al., 1964) are best
characterized; they are of'small molecular weight and
act on a later stage of viral synthesis.
The compound which we have studied was provided by
ICI Ltd. and it has been designated as 65-709. It was
shown by ICI investigators (Bucknall, unpublishen.
resUlts) that 65-709 possesses a selective antiviral
activity with a therapeutic ratio for rhinovirus type 2 ,
when grown in HEL cells of SOO. The therapeutic ratio
is defined as the ratio of'the Sa%> cytopathic concentration
of the compound to the 5a%>virus inhibitory concentration.
Ro A. Bucknall carried out preliminary studies on 65-709.
It had greatest activity against picornaviruses and
vaccinia virus and showed slight activity against arbo-
viruses and herpes simplex virus. It was not active against
respiratory syncytial virus or equine rhinovirus. The
antiviral activity was greatest in HEL cells and was
reduced in either diploid primary monkey kidney cells
or heteroploid human cells in culture. 65-709
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appeared to inhibit a replicative or maturation process
since it neither inactivated virions nor prevented their
penetration into the host cell. The compound did not
appear to bind to cellular components or cause irrevers-
ible changes to the cell since antiviral activity was
absent after removing the drug from the culture medium.
The compound, 1 -.£ - chlorophenyl - 3~..j_sobutyl thio-
ureido) phenyl guanidine gluconate, (NW 571.5) is
designated ICI 65,709 or in this thesis 65-709 al~ has
the chemical formula:
s
. II i
c'~-'.c.NH ~NH.c.NH Bu
'-=1nl ~-
NH.gluconate
The mode of action of guanidine is still an unsolved
problem despite the impressive amount of data which have
appeared in the literature during the last ten years.
Nevertheless the various suggestions made to explain its
activity will be presented here. It is generally agreed
that guanidine neither inactivates extracellular virions
nor interferes with early events of viral infection
(Crowther & Melnick, 1961; Ueda et al., 1961; Carp, 1964;
Pringle, 1964; Eggers et al., 1965). The inhibition of
cellular protein and RNA synthesis in infected cells is
not inhibited by guanidine (Baltimore et al., 1963;
Bablanian et al., 1965), although it has been demonstrated
that guanidine pr~vents the viral induced inhibition of
DNA synthesis in infected HeLa cells (Powers et al., 1969).
It was suggested in 1961 by Crowther and Melnick that
guanidine might inhibit a hypothetical virus-coded
non-virion enzyme necessary £or viral replication and
two years later the viral RNA polymerase was discovered
by Baltimore and Franklin (1963). It was shown shortly
after that guanidine affects the development of enzyme
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activity in picornavirus infected cells (Eggers et al.,
1963 ; Baltimore et al., 1963). This was a discovery of
some importance because it was thought at that time that
guanidine led to the formation of defective viral RNA,
however since guanidine inhibits development of the RNA
polymerase it means that it prevents synthesis of any
viral RNA. It should be pointed out here that guanidine
does not inhibit polymerase activity when assayed in a
cell free system (Baltimore et al., 1963)0 Consequently
it was suggested that guanidinp. prevented the synthesis
of the enzyme. This however has been challenged by more
recent experiments as will be discussed below.
Lwoff and co-workere (1962) believed that guanidine
acted allosterically upon the monomers of the replicase
in such way that it prevented them from aggL'egating to
form the active polymers (Lwoff et al., 1963; Lwoff &
Lwoff, 1964; Lwoff, 1965). Very little evidence exists
in support of Lwof£'s suggestion; the observation that
presence of guanidine for a very short time during
exponential replication is enough to show its inhibitory
effect is the evidence that guanidine acts on the
morphogenesis of the enzyme rather than its synthesis.
However Baltimore et al. (1963) and Caliguiri et al.
(1965) demonstrated that maximum inhibition is obtained
only when guanidine is present throughout the growth
cycle. This has also been confirmed in an experiment with
rhinovirus type 2 in HEL cells. ,
Caliguiri and :famm (1968a) found that treatment of
infected cells with guanidine resulted in a decrease of
the ribonuclease resistant part of the RI. This has been
explained by assuming that the target of guanidine is the
initiation of synthesis of new RNA strands. Strands
already initiated are able to be completed even in the
presence of guanidine. At the same time Baltimore (1968~
has presented evidence that guanidine blocks the processing
of ne~ly synthesized viral RNA from the replication
complex. This hypothesis is strengthened by the observation
that the RNA which is made in the presence of guanidine is
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Lha-flfound in a structure which sediments more rapidlYA0ither
viral polyribosomes or replication complex which Baltimore
called the guanidon. Thi3 hypothesis has however been
challenged by further experiments of Caliguiri and Tamm
(1968b) who showed that viral RNA molecules, ~ven when
guanidine is present, were released from the replication
complex and were subsequently incorporated into viral
polyribosomes and then into mature virions.
Finally Koschel and Wecker (1971) presented experi-
mental data which support the possibility that ~lanidine
prevents the generation of functional viral polymerase
from precursor material. Their assumption was based on
Jacobson and Baltimore1s model of translation (1968)
according to which the vi.r-a.Lgenome is transcribed in one
piece, which is translated so as to form a single
polypeptide. Cleavage of this polypeptide occurs while
it is still growing to give large precursors proteins
which are further cleaved into mature functional proteins.
This specific cleavage is believed to be inhibited by
guanidine (Koschel & We~ker, 1971).
As discussed above all the available data implicate
viral RNA polymerase as the principal target for the
antiviral activity of guanidine. However genetic analysis
of the poliovirus genome carried out by Cooperls group
(Cooper, 1968; McCahon & Cooper, 1970) has shown that
the site of guanidine resistance is located in th~ coat
protein region of the genome. This was surprising since
the RNA deficient mutants mapped at a different location
and one would have expected these and the guanidine
marker to map in the same place. To explain these findings
one can suggest that polypeptides from the ci ·sirons known
to give deficient RNA replication and guanidine markers
both contribute to polymerase activity.
Some experiments are described in this section
involving the two structurally related compounds, 65-709
and guanidine. Guanidine was used for comparative purposes
and evidence is presented to show that the modes of action
of the two compounds are not identical.
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To establish whether 65-709 and guanidine share the
same site of action, rhinovirus guanidine resistant
mutants were used. Melnick et al., in 1961, were the first
to observe development of resistance to guanidine when
they cultivated poliovirus for several passages in the
presence of increasing concentrations of guanidine. This
was soon after confirmed in several laboratories (Tamm
& Eggers, 1962; Loddo et al., 1962; Ledinko, 1963; Veda,
1963; Carp, 1963; Horodniceanu et al., 1963; Pringle,
1964)0 Rhinovirus resistant mutants were first isolated
by Acornley et al., (1968). Guanidine-dependent mutants
of poliovirus have also been obtained after repeated
passage of resistant virus in the presence of guanidine
(Loddo et al., 1963; Ledinko, 1963; Nakano et al., 1963).
The fact that resistance and dependence to guanidine is
controlled by the virus genome has been established by
the following observations:
(a) Resistance to guanidine is retained even after
several passages of the virus in the absence of guanidine
(Melnick et al., 1961; Ueda et al., 1963; Lcdil~O, 1963;
Horodniceanu et al., 1963, 1964).
(b) The viral progeny from cells infected with the RNA
extracted from resistance or dependent mutants retained
the appropriate character (Horodniceanu et al., 1964;
Loddo et al., 1962; Nakano et al., 1963; Eggers & Tamm,
1963).
(~) After treatment of type 1 and 2 poliovirus with the
mutagen hydroxy.lamine, a statistically significant
~
increase of the proportion of resistant mutants was
recorded (Klein & Teodoresku, 1968).
A further aspect of the guanidine mutants that should
be considered is the action of the so called ant;iguanidines
which are compounds antagonistic to the action of guanidine
(Philipson et al., 1966; Lwoff, 1965; Loddo et alo, 1966).
Most of these compounds contain a methyl group, an amino
group or both. Such compounds as choline, methionine and
trimethylamine are antiguanidines. The mechanism by which
these compounds antagonize guanidine inhibition is not
101
known. While the resistance character of guanidine mutants
is affected by antiguanidines, dependence is not.
Efforts to isolate mutants to 65-709 by Bucknall
were unsuccessful and he showed that antiguanidines do
not antagonize the inhibitory effect of 65-709.
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Fig. 26. Effect of 65-709 on RNA, 'DNA and protein
sYl1thesis in uninfected BEL cells. Cells were
incubated w i th 65-709 for 9 h and pulsed for 2 h
with radioactive precursors.
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Time of exposure
RI RF SS Total
to 65-709 (h)
0 to 11 70 80 67 69
7 to 11 85 65 54 59
7 to 8 26 47 2l.j· 27
Table 9. Percentage inhibi t Lori of the synthesis of
rhinovirus RNA by 65-7090 Infected cells
were treated with 2~g/ml 65-709 as indicated
and pulsed with [3H)-uridine from 9 to 11 ho
The extracted RNA was electrophoresed and
the radioactivity under each, peak
normalised with respect to optical density
markerso
107
RESULTS
1. Effect of 65-709 on macromolecular synthesis in non-
infected BEL cells. The effect of 65-709 on the synthesis
of cellular DNA) RNA and protein was determined by
incubating HEL cells in the presence of 0 to 5 ~g / ml of
65-709 for 9 h at 37°C and then by pulsing With[3H]-uridine
or a mixture of [ 14C] -thymidine and [3H] -valine. Fig. 26
shows the effect of 65-709 on the incorporation of acid-
soluble radioactivity during a 2 h pulse. Cellular RNA
synthesis was not inhibited at the concentrations used
but along with DNA and protein synthesis showed an
increased activity at 1.0 ~g / mL, DNA synthesis fell by
15% and protein synthesis by 36% at a concentration of
2 ~g / rnL,
2. Inhibition of viral RNA synthesis by 65-709. HEL cells
owere infected at 33 C and virus allowed to adsorb for
1 h. Time after infection was measured from the beginning
of adsorption. Virus was removed and replaced with warm
medium containing 2 ~g / ml 65-709. Cells were pulsed with
[3HJ-uridine for 2 h from 9 to 11 h post infection and
the RNA was then extracted and analysed by polyacrylamide
electrophoresis (Fig. 27a,b). Radioactivity under each
peak of ru~A was summed and normalised by reference to the
internal markers of ribosomal RNA measured by adsorption
at 260 nm. The overall inhibition of synthesis of viral
RNA was 69%. Individually, RI fell by 70%, RF by 80% and
SS RNA by 67% (Table 9).
RNA synthesis was inhibited by the addition of
65-709 well after viral RNA could be detected in the cell.
When 65-709 was added at 7 h post infection and the cells
pulsed from 9 to 11 h the overall inhibition was 59% and
the RI, RF and SS RNA fell by 85%. 65% and 54% respect-
ively (Table 9).
65-709 added at 1 h also inhibited the viral cytopathic
effect which extended to over 80% of the cells by 11 h
after infection.
'I
Fig. 28. Inhibition of rhinovirus multiplication
by guanidine. The yield of combined intra- and
extra-cellular virus is presented. Cytopathic
effects at the time of harvest (21 h) is
indicated by + (50% of cells affected) or ++
(over 80% of cells affected).
c,p.e,
++ ++ +
G
-
~
:J
~-Ol
o
..J
5
4
100J 10 30
Guanidine (p.g/ml)
7
(u )
2SS
6
5
-)(
--_ ~
0-
W
3
2
1
28S
20 ltO
~~·~,M./'t.~_o:!, ....~_'_--'- __
20 40
FRACTIONS
76
5
3
2
( e )
2SS
(d )
28S
1
20 40 20
FRACTIONS
40
Fig. 29. Inhibition of rhinovirus RNA synthesis
by gtzani.dLrie (100 Ilg/ m.l}, All cultures were
infected and pulsed from 9 to 11 h w i,th [ JH J-
uridine. The continuous line is the optical
density trace at 260 nrn, (a) control, (b)
guanidine included between 1 to 11 h p.i.,
(c) guanidine added between 7 to 11 h p.i. and
(d) guanidine added between 7 to 8 h p.i.
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3. Reversibility of 65-709 inhibition of viral RNA
synthesis. Cells were treated with 2 [.!.g/ ml 65-709 from
7 to 8 h'post infection and then washed twice, re-incubated
in fresh medium and pulsed with [3HJ-uridine from 9 to
11 h. Im1ibition of total viral RNA synthesis was 27%,
which was half the value obtained by treatment with
65-709 from 7 to 11 h (Fig. 27c,d and Table 9). A similar
recovery of RNA synthesis was also demonstrated when
65-709 was present from 0 to 3.5 h and cells pulsed from
5 to 7 h. Other experiments where an increase in RNA
synthesis was evident at 1 h after removal of 65-709
indicated that recovery from inhibition was a rapid
process.
4. £_.hibition of rhinovirus multiplication by guanidine.
Since 65-709 is a substituted guanidine it was important
to establish whether or not 65-709 and guanidine had
identical modes of action. The first experiments examined
some parameters of guanidine inhibition of the
multiplication of rhinovirus type 2 in BEL cells.
Rhinovirus was grown in the presence of increasing
concentrations of guanidine for 21 ho The combined yield
of extra- and intra-cellular virus was titrated by plaque
assay. Significant inhibition was observed at a concentration
of 33 [.!.g/ ml and inhibition increased to over 99.9% at
100 Ilg/ ml (Fig. 28) 0 The latter concentration was used
in the experiments on RNA synthesis described below to
ensure maximum inhibition.
5. Inhibition of rhinovirus RNA synthesis by guanidine.
The extent of inhibition by guanidine added at different
times and for varying periods was investigated by
pulsing with [3H]-uridine from 9 to 11 h after infection.
When guanidine was present from 1 to 11 h RNA synthesis
was inhibited completely and when present from 7 to 11 h
it was inhibited by 95% (Fig. 29a,b,c).
Inhibition was reversible since it was found that
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Fig. 30. Reversal of guanidine inhibition of rhinovirus
RNA synthesis. Cells were pulsed from 9 to 11 h with
[3HJ-uridineo The continuous line is the optical density
trace at 260 nrn. (a) control, (b) guanidine included in
the medium between 0 to 3.25 h p.:if"J
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Fig. 31. Effect of 65-709 and guanidine on the
multiplication of bovine enterovirus in HEL cellso
Both 65-709 and guanidine were present continuously
from 0 h. ((i)--0) control, (0---0) in the presence
of 65-709, (~) in the presence of guanidine.
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Fig. 32. E1fect of 65-709 on poliovirus and bovine entero-
virus RNA synthesis. 1 iLg/ ml 65-709 wa s present contin-
uously in the treated cultures from 0 h and all cultures
were pulsed from 9 to 11 h 'vith [3Hl-uridine. The continuous
line is the optical density trace at 260 nm. (a) control
poliovirus RNA, (b) Poliovirus RNA in the presence of 65-709,-
(c) control bovine enterovirus, (d) Bovine entero~irus RNA in
the presence of 65-709.
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after a pulse of guanidine from 7 to 8 h, RNA synthesis
was 49% of the control (Fig. 29d). Provided that sufficient
time was allowed fo.1lowing reversal of inhibition, complete
recovery of RNA synthesis was observed even wh.eri guanidine
was added at the time of infection. Fig. 30 shows that
after a pulse of'guanidine from 0 to 3.25 h, normalised
RNA synthesis measured at 9 to 11 h was 1 .6-fold greater
than the control.
6. Inhibition of bovine enterovirus and poliovirus
multiplication by 65-709 or by guanidine. Bucknall et al.,
(personal communication) have shown that 65-709 inhibited
the multiplication of a wide range of viruses in HEL cells,
although the greatest activity was against rhinoviruses.
We have extended these results by investigating the
extent of inhibition of two other picornavi~uses, bovine
enterovirus and poliovirus by 65-709 or guanidine.
(a) Cytopathic effects
Initially we found that cytopathic effects did not
appear in infected cell£: which were treated from 0 h with
100 I-Lg/ ml guanidine or in cells infected with poliovirus
which were treated wi th 1 I-Lg/ ml 65-709. However, 65-709
did not inhibit cytopathic effects caused by bovine
enterovirus.
(b) Multiplication of bovine enterovirus
HEL cells were infected in the presence of 100 I-Lg/ ml
~uanidine or 1 I-Lg/ ml 65-709 and the combined yield of
extra- and intracellular virus titrated at intervals.
65-709 had no effect on the rate of virion production or
the total number of p.f.u. produced while guanidine slowed
the rate of virion production considerably and reduced the
final yield by around 10-fold (Fig. 31).
(c) Effect of 65-709 on viral RNA synthesis
As a result of tllese observations we investigated the
synthesis of RNA by poliovirus and bovine enterovirus in
the presence of 1 IJ.g/ ml 65-709 added from 0 h (Fig. 32) 0
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We found that poliovirus RNA synthesis was reduced by 86%
and that bovine enterovirus was unaffected by the presence
of 65-709.
7. Effect of 65-709 on RNA synthesis by a guanidine-
resistant rhinovirus mutant
The resistance of bovine enterovirus to 65-709 but
not to guanidine indicated that the modes of action of the
two compounds were not identical. However, since rhino-
virus replication was inhibited by both compounds we
selected a mutant which was resistant to guanidine to see
if resistarce to 65-709 was acquired simultaneously.
RNA synthesis by the guanidine-resistant rhi~ovirus
was measured in the presence of 100 ~g/ml guanidine and
2 ~g/ml 65-709 (Fig. 33). The result was unequivocal:
guanidine had no effect while 65-709 inhibited RNA
synthesis. We concluded that the modes of action of
guanidine and 65-709 in inhibiting RNA synthesis of rhino-
virus were not identical.
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DISCUSSION
The substituted guanidine compound 65-709 specifically
inhibited the replication of rhinovirus type 2 RNA, the
production of virions and cytopathic effects in HEL cells.
RNA replication could be inhibited at any time dl1.ring
virus multiplication and the effect of the drug was
reversed by removing it from the culture medium. In these
respects the anti-viral activity of 65-709 and guanidine
itself are similar.
The maximum inhibition of virus RNA synthesis by
65-709 varied between experiments from 72% (Fig. 27) to
over 90% (Fig. 33) and had a mean value over a large
number of experiments of 85%. The extent of inhibition
of virion formation under single-step growth conditions
was comparable with inhibition of RNA synthesis. Under
the same conditions guanidine was the more effective
inhibitor, no RNA synthesis being detected and virion
formation being reduced by over 99.9%. However, since
30 ~g / ml guanidine were required to inhibit virion
formation to the same extent as 2 I-Lg/ ml 65-709, the
latter was considerably more effective on a weight basis.
On a molar basis, 65-709 (mol. wt. 571.5) was 90-fold
more effective than guanidine (mol. wt. 95.5). Despite
its relatively small inhibitory effect, 65-709 was able
to prevent the appearance of gross cytopathic changes in
cells when added at the time of infection, even though
over 80% of cells in non-treated cultures were degenerating.
A comparison of the normalised radioactivity
incorporated into single-stranded RNA, replicative form
and replicative intermediate, indicated that 65-709
inhibited all RNA species equally. The saooresult was
obtained when the drug was added at different times
during replication and with different lengths of treatment.
Guanidine inhibited RNA synthesis completely with the
relatively long treatment of our experimental conditions.
However, it would have been of interest to repeat with
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65-709, Baltimore's (1969) finding that inhibition by
guanidine was initially selective and that RF synthesis
was spared. While we do not have this information, the
continued synthesis in the presence of 65-709 of apprec-
iable amounts of all three RNA species indicated that
65-709 did not selectively inhibit RNA synthesis.
Since 65-709 and guanidine both inhibited virus RNA
synthesis, it was important to determine whether or not
their modes of action were identical. This was achieved
by selecting a rhinovirus mutant which was resistant
to guanidine and finding that the mutant had acquired no
resistance to 65-709. This result was corroborated by
the failure of 65-709 to support the growth of a polio-
virus guanidine-dependent mutant (Dimmock, N. J.,
unpublished results), by the failure to obtain rhinovirus
mutants resistant to or depend.ent on 65-709 (Bucknall,
R. A., unpublished results) and by the absence of
inhibition of bovine enterovirus RNA synth~sis and virion
production in HEL cells under conditions where guanidine
did cause inhibition.
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RESULTS PART III
"Rhinovirus induced polymerase activity.
The ef'f'ectof'ICI 65,709 on polymerase activity.1I
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INTRODUCTION
The first RNA-dependent RNA polymerase to be detected
was induced by mengovirus in mammalian cells (Baltimore &
Franklin, 1962)0 The evidence which shows that this is
the enzyme responsible for viral RNA replication comes
from the ~acts that it is found only in infected cells,
its activity is not inhibited by AMD and the RNA which
is synthesized in vitro has physicochemical properties
identical to those of the virus specified RNA's obtained
in vivo.
An RNA-dependent polymerase has been purified by
several investigators working with bacteria infected with
RNA phages (Haruna & Spiegelman, 1965; August & Eoyang,
1967; Feix et al., 1968; Kondo et al., 1970). The purified
polymerase has been used to analyse RNA replication in
vitroo The template requirement is one of the most
striking properties of the purified enzyme. It will only
transcribe single stranded RNA from the parental virus
(Haruna & Spiegelman, 1965)0 Not even the RNA of a closely
related ba serologically distinct virus can be transcribed.
It can use both plus or minus strands but has a greater
affinity for minus strands. Infectious RNA is synthesized
when non-infectious minus RNA strands are used as template
(Feix et al., 1968).
The subunit structure of the Q~ replicase has been
e1ucidated by Kondo et al. (1970) and Kamen (1970).
Working independently they both found that purified Q~
replicase consisted of four polypeptides a, ~,1andb
of molecular weight 70,000, 65,000, 45,000 and 35,000
da1tons respectively. The Q~ RNA has been estimated to
code for 150,000 daltons of protein. The MW of the virion
structural proteins is 90,000 daltons, 1eaving a spare
coding capacity for a protein of 60,000 daltons. Since
the total MW of the four replicase subunits is much
higher than 60,000, the investigators predicted and soon
afterwards confirmed that some of the replicase poly-
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peptides are of host origin. In fact both Kondo et al.
(1970) and Kamen (1970) showed that only polypeptide f3
is virus specified, while polypeptides a,~ and S are
present in non-infected cells and are host cell specific
proteins. The host cell components appear essential for
polymerase activity since Kamen (1970) found that neither
complexes of a and f3 or ~ and S were active. Howev er:
activity was restored by mixing the two inacti~e
components. In addition the host components are not found
associated together in uninfected cells.
It has been proved ve~ difficult to purify RNA
polymerases from eukaryotic cells infected wjth animal
viruses. This is probably due to the relatively low amount
of the enzyme activity in these systems and particularly
to the fact that the replicase is firmly bound to smooth
cytoplasmic membranes. Lack o~ an enzyme preparation
capable of using a synthetic polyribonucleotide template
has also hindered work on purification of the enzyme.
Recently Rosenberg et al. (1972) reported the isolation
of a poly C - dependent RNA polymerase from BHK ;~1 cells
infected with EMC virus. Treatment with 20 mM dithio-
threitol and 0.05% triton X-100 separated the membrane
material from the replication complex. At this stage the
template RNA became sensitive to the action of micrococcal
ribonuclease which freed the replicase from its template
while permitting the synthesis of poly G upon addition of
poly C template. SDS polyacrylamide gel electrophoresis
of the enzyme revealed five polypeptides of MW 72,000,
65,000, 57,000, 45,000 and 35,000. Four of the polypeptides
seem to have identical molecular weights to the Qf3
replicase polypeptides. At this stage it is not known
whether all five polypeptides are true subunits of the
enzyme.
Yin and Knight (1972) have detected polymerase activity
from HeLa cells infected with rhinovirus type 2. The
fractionation procedure described by these investigators
has been followed to obtain the enzyme fraction used in
our studies. The enzyme assay described in the same report
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has been used for polymerase activity assays.
As it has been mentioned in the introduction of
"Results Part II", the various hypotheses to explain the
mode of action of guanidine involve inhibition of the
RNA-dependent RNA polymerase activity. This, together
with the fact that viral RNA synthesis is effected by
65-709 (Results Part II) led us to the experiments
described in this section. A sensitive assay to study
the products of the replication process in vitro was
first established and the effect. of 65-709 on RNA-
dependent RNA polymerase in vivo and in vitro was then
investigated.
Reaction
mixture
CPM/mg protein/h
at 33°C
Source of enzyme
fraction
complete
complete
-ATP,-CTP,-UTP
M ++- g
completed but
incubated at
OoC
complete
- 8,120
Non infected cells 42,360
Infected cells 92,960
" 8.5,400
II 78,160
" 195,680
Table 100 Rhinovirus induced polymerase assay.
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Fig. 34. Electrophoresis of the polymerase products. The
polymerase fraction extracted from infected HEL cells
was assayed wLth the complete polymerase assay mix.ture
and an assay mixture from wh Lch the 3 cold triphosphates
were omitted. The RNA was then extracted and analysed
by polyacrylamide gel eJectrophoresis. The continuous
line is the OD260 trace indicating the position of 28S
and 18S r.ibosomal RNA.
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RESULTS
Ao Studies on rhinovirus induced RNA polymerase.
Some experiments are described in this section which
establish a sensitive assay for the effect of 65-709 on
the rhinovirus induced RNA polymerase.
1. Polymerase activity as measured by TCA-precipitable
radioactivity.
Yin and Knight (1972) have reported that rhinovirus-
induced RNA-polymerase activity obtained from infected
HeLa cells is dependent on the presence of both the four
nucleoside triphosphates and magnesium ions. The Yin and
Knight fractionation procedure was applied to an extract
of HEL cells infected with rhinovirus type 2 and the
enzyme fraction was then assayed using the assay mixture
described by the same investigators (Table 10). There
was considerable incorporation of [3H]-GTP with the
complete assay mixture but controls reached nearly 50%
of this value. Various methods were applied in order to
wash the radioactivity from the controls without much
success. Infected HeLa cells gave similar results.
2. Analysis of polymerase products
The question was asked whether any of the radio-
.activity which was precipitated by TCA was specifically
incorporated into rhinovirus RNA.
An enzyme preparation was split into two portions,
one which was assayed with a complete polymerase assay
mixture, the other with an assay mixture from which
the three cold triphosphates were missing. The RNA from
these preparations was extracted with phenol and was
analysed by polyacrylamide gel electrophoresis. The results
in Fig. 34 show that three species of RNA could be
distinguished from the complete assay mixture. However, no
Iradioactivityabove background was present when the three
/
cold triphosphates were omitted. We concluded that the
128
control TCA-precipitable radioactivity was not incorporated
into virus-induced RNA and is presumably adsorbed non-
specifically to cellular material or incorporated in low
molecular weight RNA.
3. Comparison of RNA's synthesized in vivo and in vitro.
The RNA species synthesized in vitro were identified
by co-electrophoresis with RNA induced in vivo. The RNA
preparations were labelled in vivo with [14C]-uridine
and in vitro with [3H]-GTP. Tnese were mixed and electro-
phol'esed on polyacrylamide gel. Fig. 35 shows an absolute
coincidence of the RI, RF and SS RNA prepared in vivo
with the 3 RNA peaks obtained in vitro. The amount of
SS RNA obtained in vitro is very small in relation to
that obtained in vivo; this will be considered during
the discussion of this secUon.
4. Time course of polymerase activity.
The RNA-dependent RNA polymerase activity induced in
HEL cells after rhinovirus infection was assayed at
various times after infection and the products of the
in vitro assay were analysed by polyacrylamide gel
electrophoresis (Fig. 36). The number of counts under
the 3 peaks of RNA were calculated and normalised with
respect to the 28S ribosomal RNA present in each
preparation (Table 11). The total radioactivity in the
peaks was normalised and plotted against time after
infection (Fig. 37). Polymerase activity was first
detected at 6 h after infection. This was also the
earliest time that RNA synthesized in vivo was detected
(see Chapter I). Total polymerase activity increased
until 9 h p.i, and then appe~red to decrease.
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Fig. 35. Co-electrophoresis of RNA prepared in
vivo (~), and in vitro (~). The continuous
line is the OD260 trace indicating the position of
the ribosomal RNA.
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Fig. 36. Electrophoresis of the polymerase products.
Polymerase fraction was extracted at the indicated
times after infection and was assayed with the ~omplete
polymerase assay mixture. The products of the
polymerase are shown as analysed by polyacrylamide
gel electrophoresis. The continuous line is the OD260
trace indicating the position of the 288 ribosomal
RNA.
Time after infection
(h) CPM %
2 88 5.4
4 211 13.0
6 820 50.4
7.5 1 ,009 62.1
9.25 1 ,624 100.0
11 1 ,429 88.0
Table 11. Rhinovirus induced polymerase activity at
different times afier infection as estimated
from the products of the enzymic reaction.
Data obtained from Fig. 36.
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Fig. 37. Rhinovirus induced polymerase activity as a
function of the time after infection. 'Data from Fig. 36.
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Fig. 38. Effect of 65-709 on polymerase activity in
vitro. 10 I-Lg/ ml of 65-709 were included in the
polymerase assay mixture. The products of the enzymic
reaction are sh own as analysed by polyacrylamide gel
electrophoresis, (a) control (b) assayed in the presence
of 65-709.
135
B. Effect of 65-709 on rhinovirus induced polymerase.
We have shown in ~esults Part II' that the antiviral
compound 65-709 inhibited the replication of viral RNA in
vivo. We also established an in vitro system for the study
of RNA polymerase activity. In a continuing study to
determine the mode of action of 65-709 we Lrrve st Lg'a t ed
the effect of 65-709 on polymerase activity in the
following experiments.
1. Effect of 65-709 and guanidine on the polymerase
activity in vitro.
Baltimore et al. (1~63) reported that the accivity
of the polymerase induced by poliovirus in HeLa cells
was not inhibited when it was assayed in the presence of
guanidine.
The effect of 65-709 and guanidine on the polymerase
induced by rhinovirus in HEL cells was first tested by
measuring the TeA-precipitable counts after incubation of
the enzyme with the usual assay mixture in the presence
of either 65-709 or guanidine. Neither of the two compounds,
even when used at concentrations 10 times greater than
the inhibitory concentrations required in vivo, had the
slightest effect on the activity of the enzyme. In order
to confirm this result the products of the in vitro assay
in the presence or absence of 65-709 were analysed (Fig.
ja). No differences were detected.
2. Effect of 65-709 and guanidine on polymerase activity
in vivo.
It has been shown in the previous experiment that
neither 65-709 or guanidine affected the polymerase activity
when the compounds were included in the assay mixture.
Since both compounds inhibited the viral RNA synthesis
in vivo ( see Results Part II ) their affect on the RNA-
dependent RNA polymerase was tested in vivo.
Both'compounds were added to infected HEL cells at
--.' I ." 1-~
(a) (b )
4 - 2aS
2aS
!3
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Fig. 390 Effect of 05-709 and guanidine on poly-
merase activity in vivu. Both compounds were
included in the medium of tIle infected HEL cells
between 7.5 - 11 h after infection. The polymerase
fraction was then extracted, assayed with the
complete polymerase assay mixture and analysed by
electrophoresis. (a) control at 7.5 h p.i.,
(b) control at 11 h p.i. (c) 65-709 treated cells
and (d) guanidine trea~ed cells. The continuous
line is the OD260 trace indicating the position
of the 288 ribosomal RNAo
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-Sample CPM %
Control at 11 h poi. 1 ,429 10000
Control at 7.5 h p.i. 1 ,009 7006
65-709 treated
between 7.5 - 11 h 330 2301
poi.
Guanidine treated
between 7.5 - 11 h 462 32.3
p.i.
Table 12. Effect of 65-709 and guanidine on virus induced
polymerase in vivo. The radioactivity above
background (data from Fig. 39) was calculated
and normalised as previously describedo
Sample
Control cells
Cells treated with
65-709 for 3 h
Cells treated with
cycloheximide for
45 min
Cells treated with
65-709 for 3 hand
subsequently with
cycloheximide for
45 min
TCA-precipitable
CPM
3.4
11 t 097 100
8,344 75.2
380
372
Table 13. Effect of cycloheximide on cellular protein
synthesis. 65-709 and cycloheximide were used
at concentrations of' 1llg/ml and 3001lg/ml
respectively. It is shown that the cyclo-
heximidets inhibition of protein synthesis
is not affected by pretreatment of the cells
with 65-709.
4000
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Fig •.40. Effect of cycloheximide on the polymerase
activity in vivo. Cycloheximide was included in the
medium of the infected cells at a concentration of
300 l-lg/ mL The products of the polymerase are shown
as analysed by electrophoresis. (a) control, (b) and
(c) infected cells treated w i th cycloheximide for 45
min and 305 h respectively.
7t h after infection at the same concentrations used on
previous occas ions (1 l-Lg/ ml for 65-709 and 100 l-Lg/ ml for
guanidine). The activity of the enzyme was tested at 11 h
after infection and was compared with that of non-treated
infected cells by extraction of the RNA from the assay
mixture and analysis by polyacrylamide gel electrophoresis
(Fig. 39). The radioactivity above background was
calculated and normalized as previously described. (Table
12). Incubation of the infected cells with 65~709 or
guanidine for 3t h resulted in a 77% and a 68% inhibition
of the polymerase activity respectively.
3. Effect of cycluheximide on protein synthp.sis in cells
pretreated with 65-709.
In the last experiment of this section (ExP. B 5)
cycloheximide is used to inhibit protein synthesis during
a further investigation of the effects of 65-709 on the
virus induced polymerase. This experiment was designed to
show that protein synthesis is still inhi1:>itedby cyclo-
heximide when the cells have been pretreated with 65-709
since it was possible that 65-709 Inight affect the uptake
or action of cycloheximide.
Confluent-monolayers of HEL cells were treated with
1 l-Lg/ ml 65-709 or left untreated for 3 hours. At the end
of this period 300 !lg/ ml of cycloheximide were added to
half of the plates and incubation continued for a further
45 min. During the last 15 min of the incubation period
all plates received a pulse of [3H]-protein hydrolysate
(6 IJ,c/plate) and the TCA-precipitable radioactivity was
determined. Table 13 shows that the same inhibition of
protein synthesis by cycloheximide was obtained whether
or not cells were pretreated with 65-709.
4. Stability of polymerase activity.
Cycloheximide was used to inhibit protein synthesis
so that the stability of existing polymerase activity
could be determined.
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When cycloheximide (300 l-Lg/ ml) was present in the
infected HEL cells for 3~ h (between 7~ - 11 h p.i.) no
polymerase activity was detected, as revealed by analysis
of the polymerase products (Fig. 40)0 When cycloheximide
was present for as little as 45 min the activity of the
polymerase decreased by 54%0 Similar results with polio-
virus induced polymerase have been interpreted as
indicating that the enzyme has a short half life in vivo
(Baltimore, 1968~.
5. Does 65-709 prevent the synthesis or the maturation of
the polymerase?
If 65-709 inhibits the synthesis of the polymerase,
then removal of 65-709 ~nd addition of cycloheximide to
infected cells pretreated with 65-709 should result in the
normal rapid decay of the small amount of the enzyme
synthesized in the presence of 65-709. If the enzyme is
synthesized in the presence of 65-709 but for some reason
is not active, then removal of 65-709 might allow the
inactive enzyme to attain an active configuration.
Experimentally this could be shown by adding cycloheximide
at the time of removal of 65-709 and would be reflected
by an apparently lower r&te of inactivation of polymerase
activity than in the drug treated control.
Infected HEL cells were divided into four groups:
(a) was the control and did not receive any drug treatment •
.(b) was treated with 300 l-Lg/ ml cycloheximide between 11 -
11.75 h p.i.
(c) was treated with 1 l-Lg/ml of 65-709 between 7.5 - 11 h
p.i. and with cycloheximide between 11 - 11.75 h p.i., and
(d) was treated with 65-709 between 705 - 11.75 h p.i.
At 11.75 h after infection the polymerase fraction was
extracted and assayed with the complete assay mixture. The
products of the enzymic reaction were extract~d and analysed
by polyacrylamide gel electrophoresis (Fig. 41). Cyclo-
heximide alone reduced the polymerase activity to 46%
(Fig. 41 a and b). When cycloheximide was added to 65-709
pretreated cells the polymerase activity was found to be
43
':'0..-
(c )( b)
20 30
fRAC liONS
Fig. 41. The amount of' inactivation of polymerase'
activity :Cram in:fected cells pretreated with 65-709
compared ,.,iththat of non-treated cells. (a) control,
(b) infected cells treated with cycloheximide b~tween
11 - 11.75 h p.i. (c) infected cells treated with
65-709 between 7.5 - 11 h p.i. and cycloheximide
betwe en 11 - 11.75 h p.i. and (d) cells treated wi th
65-709 between 7.5 - 11.75 h p~i.
Sample CPM
~----------------------4-----------------~----------------
I
Control at 11.75 h
Cells treated with
cycloheximide
between 11 - 11.75 h
Cells treated with
65-709 between 7.5
- 11 h and cyclo-
heximide between
11 - 11.7.')h
Cells treated with
65-709 between 7.5
- 11.75 h
44,660
20,880
16,290
11 ,950
100
46
36
27
Table 14. The amount of in.activation of polymerase from
65-709 pretreated cells by cycloheximide as
compared to the rate of inactivation of the
enzyme in non treated cells. Data from Fig. 41.
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at the same level as the control and even higher (Fi€;'.l-J.1 d
and c). A summary of the results obtained is presented in
Table 14. We consider that this evidence is consistent
with the,second hypothesis outlined above and indicates
strongly that 65-709 allowed the synthesis of polymerase
but that polymerase remained in an inactive form. Removal
of 65-709 allowed the inactive polymerase to attain its
functional configurationo
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DISCUSSION
We have found that the requirements for the in vitro
assay of the RNA-dependent RNA polymerase induced by
rhinovirus typP. 2 in HEL cells were very similar to
those described by Yin and Knight (1972). Incorporation
of radioactive GTP was measured by TCA precipitation and
the precipitates collected by filtration or centrifugation.
The results obtained with th~ two procedures were very
similar. Table 10 shows that the radioactivity obtained
with the various controls was nearly 50% of that with
the complete assay mixture. However, when RNA was extracted
from the controls and electrophoresed on polyacrylamide
gels no RNA species were resolved whereas with the
complete reaction mixture viral RNA species were evident
(Fig. 34). On the nature of the radioactivity obtained
from the control polymerase assays our experimental
data suggest:
a. Since no RNA was observed after electrophoresis its
size must be less than 10S.
b. The appearance of this material is not cell specific
since the same phenomenon was observed when viral
polymerase obtained from HeLa cells was assayed.
c. The very low value of radioactivity obtained when
the enzyme fraction was omitted suggests that a non-
specificbindillg of the radioactive GTP to some cellular
material which is TCA insoluble might occur.
No one has attempted so far to analyse the products
of the rhinovirus-induced polymerase. We have used
polyacrylamide gel electrophoresis to compare the viral
RNA species prepared jn vivo and in vitro. Fig. 35 shows
that the viral RNA species prepared in vitro had
identical electrophoretic mobilities to those synthesized
in vivo but very little SS RNA was detected in the in
vitro preparation. Among the explanations which could
account for this are: a. The polymerase fraction contains
ribonuclease which degrades the newly synthesized SS RNA.
However since the single stranded regions of th~ RI are
.. '1"'"'"T,
also susceptible to ribonuclease (see Results Part I)
we should expect to see a reduction in RI and to find
that the predominant species was double stranded RNA.
b. The ~ewly synthesized fu~A single strands are not
released from the replicative intermediate. ~his process
might require a cellular factor which was lost during
the fractionation of the enzyme. In this case the ratio
RI : RF should be much higher than that found in vivo.
In fact the ratio RI : RF synthesized in vivo was about
1 while the corresponding ratio obtained in vitro was
about 305. These values were consistent over a large
number of experiments.
The kinetics of the synthesis of active enzyme
appeared to be as expeGted: polymerase activity appeared
at 6 h coincident with RNA synthesis which was also
detected at 6 h after infection (Figso 18 and 37). Only
late in infection did the relationship between increasing
polymerase activity in vitro and RNA synthesis in vivo
diverge: while in vivo RNA synthesis continued to
increase with time the polymerase activity reached a
maximum at 9 h after infection and then declined.
Whether this is a real difference cannot be decided at
this stage since the two experiments were not carried
out simultaneously. The point requires further experi-
ments before it can be clarified.
It is known that poliovirus induced RNA polymerase
has a half life of 15 mins (Baltimore, 1968~. Cyclo-
heximide which is a potent inhibitor of protein
synthesis has been used to study the stability of the
rhinovirus induced enzyme. Although our experiments were
not sufficiently extensive to determine with accuracy
the half life of the enzyme it is apparent that the
rhinovirus-induced polymerase was about as unstable as
the poliovirus induced polymerase (Fig.~O).
When the compound 65-709 was included in the in vitro
polymerase assay it did not affect polymerase activity.
The same result was obtained even when the concentration
of the compound was increased 10-fold over that used in
1lJ8
the in vivo experimentso Guanidine was also used at very
high concentrations (1,000 llg/ m.l] and did not affect
the activity of the enzyme. This finding if; in agreement
with Baltimore et al. (1963), who finds that guanidine
does not affect the activity of the polymerase extracted
from HeLa cells infected with poliovirus. However the
amount of enzyme activity extracted fr-om infected cells
which had been treated with either 65-709 or gu~nidine
was 23% and 32% respectively of the control value. The
latter experiment clearly indicates that both compounds
are only inhibiting the polymerase activity in vivo.
This could mean that 65-709 and guanidine inhibited
synthesis of the enzyme polypeptide(s) or that synthesis
of the enzyme polypeptide(s) continues normally but
mature active enzyme is not formed. If the second
possibility was correct it was possible that preformed
but inactive polymerase polypeptides could mature once
the 65-709 block was removed. This would become apparent
if total protein synthesis was inhibited. Through this
experiment we found that the small amount of polymerase
activity present in 65-709 treated cells was more stable
than in con tr-oLtc eLl.s , Thus since there is no reason to
suppose that 65-709 should enhance polymerase stability
per se (although this must be checked) it appeared that
inactive polymerase was synthesized in the presence of
65-709.
It would also be interesting to repeat these
experiments to see if guanidine has a similar mode of
action.
CONCLUSIONS
1. A system for the study of the replication of rhino-
virus type 2 RNA has been established using diploid
human embryo lung cells.
2. Three species of RNA in extracts of infected cells have
been separated; in order of decreasing electrophoretic
mobility they are single-, double- and multi-stranded
RNA's.
3. Viral SS RNA was 4% of the ribosomal RNA present in
infected HEL cells.
4. Viral SS RNA from extracts of infected cells has been
shown to have identical ele~trophoretic mobility with
virion RNA.
5. The possibility of chasing radioactive uridine with
cold uridine in eukariotic cells has been stud~ed and
has been used to establish the intermediate role in
virus replication of the MS RNA. Short pulse label
technique led us to the same conclusion.
6. It has been established that hydrogen bonding between
different viral RNA molecules is not an artefact of
phenol extraction.
7. Only 4% of the viral SS RNA found in il~ected cell
extracts late after infection is encapsidated into mature
virions.
8. Treatment of RI by ribonuclease under defined
conditions converts its electrophoretic mobi.lity to that
of RF.
9. The electrophoresis of mixtures of SS RNA synthesized
early and late in infection showed no differences in
size. This observation was confirmed with a bovine entero-
virus.
i50
10. The molecular weight of native viral RNA has been
estimated by polyacrylamide electrophoresis to be
2.8 x 106 dal tons. This has been done 'vith sorneaccuracy
since HeLa nucleolar RNA's were used as molecular weight
standards.
11. The native form of poliovirus type 1 SS RNA was
smaller than rhinovirus RNA.
120 Some differences in the kinetics of synthesis of
viral RNA's in HEL and HeLa c~lls were observed and the
possibility that these differences reflecting an aspect
of cellular control of virus transcription was discussedo
13. The antiviral compound ICI 65-709 inhibited the
synthesis of all viral RNA species.
140 The antiviral activity of ICI 65-709 was compared
with that of guanidine; some differences were found.
15. Guanidine-resistant mutants of rhinovirus were
preparedo Since they were not resistant to ICI 65-709
it was concluded that the two compounds did not have
identical modes of action.
16. An in vitro assay of the rhinovirus-induced RNA-
dependent RNA polymerase has been established.
17. The rhinoviru~ polymerase was unstable in vivo and
its half life was approximately as short as that of
poliovirus-induced RNA polymerase.
18. Evidenpe was presented which suggested that the
absence of SS RNA synthesis in vitro was due to the
failure of RI to release newly synthesized strands of
RNA rather than the degradation of RNA by ribonucleaseo
19. Neither guanidine nor ICI 65-709 inhibited the
synthesis of viral RNA in vitro.
151
200 Rhinovirus-induced rn~A polymerase activity was
inhibited by ICI 65-709 in vivo. Evidence was pr~sented
wh i ch suggested that ICI 65-709 inhibited the maturation
of polymerase activity rather than the synthesis of
pol~nerase pOlypeptide(s).
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adenosine triphosphate
baby hamster kidney
chick embryo fibroblasts
cytopathic effect
counts per minute
cytidine triphosphate
deoxyribonucleic acid
deoxyribonuclease
double stranded
ethylenediaminetetraacetic acid
(di-sodium salt)
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foot and mouth disease virus
guanosine triphosphate
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DNAse
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PBS
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mouse encephalomyelitis
multi stranded
phosphate buffered saline
post infection
plaque forming units
replicative form
replicative intermediate
ribonucleic acid
ribonuclease
sodium dodecyl sulphate
single stranded
standard saline citrate
trichloroacetic acid
tris-hydroxy methyl amino methane
uridine triphosphate
p.i.
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RI
RNA
RNAse
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SSC
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UTP
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